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You are the Sovereign
Holy One, LORD
Worshipped, Magnified
Honored, Adored.

Intercessor, Advocate
Counselor, Friend
Faithful Emmanuel
On whom I depend.

“Whatever you do, work at it with all your heart,
as working for the Lord, not for men.”
Colossians 3:23

“Commit your works to the LORD,
and your thoughts will be established.”
Proverbs 16:3
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EYE MOVEMENT MEASURES OF COGNITIVE CONTROL
IN CHILDREN WITH TOURETTE SYNDROME
Publication No.___________
Cameron Beth Jeter, Ph.D.
Supervisory Professor: Anne B. Sereno, Ph.D.
Tourette Syndrome begins in childhood and is characterized by uncontrollable repetitive
actions like neck craning or hopping and noises such as sniffing or chirping. Worst in early
adolescence, these tics wax and wane in severity and occur in bouts unpredictably, often
drawing unwanted attention from bystanders. Making matters worse, over half of children with
Tourette Syndrome also suffer from comorbid, or concurrent, disorders such as attention deficit
hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). These disorders
introduce anxious thoughts, impulsivity, inattention, and mood variability that further disrupt
children with Tourette Syndrome from focusing and performing well at school and home. Thus,
deficits in the cognitive control functions of response inhibition, response generation, and
working memory have long been ascribed to Tourette Syndrome. Yet, without considering the
effect of medication, age, and comorbidity, this is a premature attribution. This study used an
infrared eye tracking camera and various computer tasks requiring eye movement responses to
evaluate response inhibition, response generation, and working memory in Tourette Syndrome.
This study, the first to control for medication, age, and comorbidity, enrolled 39 unmedicated
children with Tourette Syndrome and 29 typically developing peers aged 10-16 years who
completed reflexive and voluntary eye movement tasks and diagnostic rating scales to assess
symptom severities of Tourette Syndrome, ADHD, and OCD. Children with Tourette Syndrome
and comorbid ADHD and/or OCD, but not children with Tourette Syndrome only, took longer to
respond and made more errors and distracted eye movements compared to typicallydeveloping children, displaying cognitive control deficits. However, increasing symptom
severities of Tourette Syndrome, ADHD, and OCD correlated with one another. Thus,
cognitive control deficits were not specific to Tourette Syndrome patients with comorbid
conditions, but rather increase with increasing tic severity, suggesting that a majority of
Tourette Syndrome patients, regardless of a clinical diagnosis of ADHD and/or OCD, have
symptoms of cognitive control deficits at some level. Therefore, clinicians should evaluate and
counsel all families of children with Tourette Syndrome, with or without currently diagnosed
ADHD and/or OCD, about the functional ramifications of comorbid symptoms and that they may
wax and wane with tic severity.
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1. Chapter 1

Introduction
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In 1885, Georges Gilles de la Tourette first described nine patients with compulsive tics
(Gilles de la Tourette, 1885). Gilles de la Tourette’s mentor and the father of modern
neurology, Jean-Martin Charcot, chose the eponym Gilles de la Tourette illness, now more
commonly known as Tourette Syndrome (TS). While widely documented in the late 1800’s, TS
was not often detailed again until Arthur Shapiro and others published a monograph in the late
twentieth century (Shapiro et al., 1978).

Diagnosis and Prevalence
Tics are brief, repetitive, stereotyped (i.e., unoriginal, patterned) movements or noises.
Intriguingly, tics often appear as segments of familiar motor movements or phonic sounds yet
are improper for the situation. Physicians classify tics by their anatomical location, number,
frequency, duration, intensity (i.e., exaggerated nature or volume), and complexity (i.e., extent
of muscles involved or sounds versus syllables or words produced; Leckman et al., 2006a).
Parents often overlook simple motor and occasional vocal tics. Children suppress or
hide tics in the doctor’s office, leading many general practitioners to miss tics or mistake those
observed as symptoms of allergies or “nervousness,” resulting in referrals to ophthalmologists,
allergists, or psychologists. This only delays proper diagnosis and treatment, amplifying family
distress (Bruun and Budman, 2005; Zinner, 2006).
Further complicating definitive diagnosis, no clinical examination or laboratory test (e.g.,
blood test or neuroimaging result) exists. Thus, a trained neurologist must base diagnosis on
family history, clinical interview, and brief observation. For diagnosis, neurologists widely use
the criteria listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) from the American Psychiatric Association. Thus, TS is differentiated from transient
tic and chronic tic disorders when multiple motor and one or more vocal tics have been present
for over a year, with no more than three tic-free consecutive months. Onset must be before the
age of 18 and cannot be the result of drugs or other medical condition (APA, 2000).
Although tics occur in up to a quarter of all kids at sometime during childhood (Kurlan et
al., 2002; Snider et al., 2002; Robertson, 2003; Khalifa and von Knorring, 2003), only about 1%
of children meet diagnostic criteria for TS (Comings and Comings, 1990; Robertson, 2008).
Once thought rare, TS may in fact be under diagnosed because of inconsistent diagnostic
criteria and a decrease of perceived distress and impairment in some cultures leading to fewer
clinic visits (Robertson, 2003). Whether TS is increasing in prevalence, however, is uncertain.
There is undoubtedly increased public awareness of TS, but current studies cannot confirm an
2

actual increase in TS (Robertson et al., 2009). Found four times as often in boys than girls
(Freeman et al., 2000), TS affects most all cultures equally, emphasizing the biological, rather
than psychiatric, foundation of the disorder (Robertson et al., 2009).
Motor tics are classified as simple or complex. A simple motor tic is a brief, sudden,
purposeless movement, typically involving a single muscle. Simple motor tics usually occur in
runs, though not always at the same anatomical site. The most common simple motor tics
include forceful eye blinking, mouth movements, nostril flares, and shoulder shrugs. An
extended, but in no way exhaustive, list appears in Table 1.1. Younger patients are often
oblivious to their simple motor tics.
As patients mature, simple motor tics are joined by complex motor tics, which are
sudden, coordinated, and seemingly purposeful sequential movements of multiple muscle
groups over a longer duration. Examples are endless and include head jerks to toss the hair,
neck craning followed by a shoulder shrug, and walking interjected with choreographed hops.
Patients are often very aware of their complex motor tics, which with increased frequency and
intensity often lead to physical pain and fatigue. Further, complex motor tics can be
emotionally painful, drawing unwanted stares from bystanders, opening the door for loneliness
and low self-esteem. In response, patients will camouflage tics to make them appear
purposeful (e.g., arm jerk ending in smoothing the hair). Consequently, a frequent lip-pursing
tic may be less impairing than an infrequent obscene gesture.
Moving air through the nose, mouth, or throat produces vocal tics, also called phonic
tics (Fahn, 2005). This leads to a nearly endless range of possible vocal tics, some captured in
Table 1.1. As with motor tics, vocal tics are categorized as simple or complex. A single sound,
such as a snort, tongue click, or bird chirp qualifies as a simple vocal tic. These sudden,
meaningless noises occur in bouts of repeated succession. Complex vocal tics are comprised
of syllables, words, phrases, or variations in speech patterns, such as stuttering or repeating
oneself (palilalia) or another (echolalia). Contrary to media portrayal of TS, only around 10% of
patients have coprolalia – obscene and socially inappropriate remarks (Goldenberg et al.,
1994; Freeman et al., 2000).
One intriguing aspect of tics is their suggestibility. This feature is discernable in multiple
settings. During clinical observation and, more specifically, during a structured, systematic
interview of current and past symptoms, mentioned tics may appear immediately (often
unbeknownst to the child), even if the tic had been absent for months (Leckman et al., 2006b).
Suggestibility extends beyond an individual’s personal repertoire of tics. Astonishingly, patients
in the waiting room of a TS specialty clinic would mimic the tics witnessed in other waiting,
3

Table 1.1 Examples of simple and complex motor and vocal tics
Tic Symptom Dimensions
Simple motor tics:
Sudden, brief, meaningless movements

Examples
Eye blinking, eye movements, grimacing,
nose twitching, mouth movements, lip pouting,
head jerks, shoulder shrugs, abdominal
tensing, kicks, finger movements, jaw snaps,
rapid jerking of any part of the body

Complex motor tics:
Slower, longer, more “purposeful” movements

Sustained “looks,” facial gestures, biting,
touching objects or self, thrusting arms,
throwing, banging, gestures with hands,
gyrating and bending, dystonic postures,
copropraxia (obscene gestures)

Simple phonic tics:
Sudden, meaningless sounds or noises

Throat clearing, coughing, sniffling, spitting,
screeching, barking, grunting, gurgling,
clacking, hissing, sucking, animal noises, and
innumerable other sounds

Complex phonic tics:
Sudden, more “meaningful” utterances

Syllables, words, phrases, statements such as
“shut up,” “stop that,“ “oh, okay,” “I’ve got to,”
“honey,” “what makes me do this?” “how
about it,” or “now you’ve seen it,” speech
atypicalities (usually rhythms, tone, accents,
intensity of speech); echo phenomenon
(immediate repetition of one’s own [palilalia] or
another’s words or phrases [echolalia]); and
coprolalia (obscene, inappropriate, and
aggressive words and statements)

From Leckman LF, King RA, Cohen DJ. Tics and tic disorders. In: Leckman JF, Cohen DJ
with Colleagues from the Yale Child Study Center. Tourette’s Syndrome – Tics, Obsessions,
Compulsions: Developmental Psychopathology and Clinical Care. New York: John Wiley and
Sons; 1998:23-42. Reprinted with permission.
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ticcing patients (Ian J. Butler, personal communication). This latter example of suggestibility
demonstrates tic response to external, and often unconscious, stimuli (e.g., scratchy shirt tag).
Many children with TS report an urge preceding a tic (Banaschewski et al., 2003). Like
an itch before a scratch, this premonitory urge only becomes harder to ignore the longer the tic
is resisted. Once the tic is released, children experience fleeting relief until the urge inevitably
returns. Indeed, a tic’s irresistibility has been cited as its most prominent feature, “The strain in
holding back is as great as the relief in letting go” (Wilson, 1940). Of note, it is detection of the
urge (often not recognized until preteen years) that alerts kids to attempt to suppress, or hold
in, a forthcoming tic. Unfortunately, of the tics TS patients can only hold in, restraint is only
temporary (few minutes to an hour; Banaschewski et al., 2003). Despite tics long being
classified as entirely involuntary and reflexive (Meige and Feindel, 1907), this ability to
suppress tics, albeit momentarily, indicates some voluntary or willful control. Hence, Lang
proposed the involuntary label of tics be reevaluated (Lang, 1991). In response, Fahn has
offered the term unvoluntary, as tics are seemingly a voluntary response to an involuntary
sensation (Fahn, 2005).

Natural History
Tourette Syndrome has an interesting natural history, or classical pattern of
development. Motor tics appear first, around the age of five to seven (Freeman et al., 2000;
Leckman et al., 2006a; Zinner, 2006), joined by vocal tics on average two years later,
somewhere between 8-15 years of age (Peterson, 1996; Leckman et al., 2006a). Tics
progress in a rostral-caudal manner, first affecting the face and head (e.g., eye blinking, head
bobbing, and neck craning), then the torso (e.g., abdominal flexing and shoulder shrugging),
and finally the limbs (e.g., finger tapping and knee bouncing; Singer and Walkup, 1991; Bruun
and Budman, 2005). Furthermore, tics begin as simple and meaningless, involving usually only
one muscle group. As the child enters the preteen years, new tics take on a complex nature
involving a combination of muscles and sounds that appear almost purposeful. For example, a
child with Tourette Syndrome often begins with simple, forceful eye blinks and eye rolls, which
later disappear or are joined by a complex tic, such as the combination of a shoulder roll
accompanied by a neck crane. As one can imagine, motor and particularly vocal tics draw
unwanted attention from bystanders and classmates leading to social stigma, complicating the
daily life of a child with Tourette Syndrome.
As implied above, tics change in identity over time and individual tics also change in
frequency and severity. Unfortunately, this fluctuation is largely unpredictable. Features of tics
5

contributing to overall severity are displayed in Table 1.2. A given tic may appear for a few
weeks or may persist for years. During the presence of one tic, other tics will surface (Bruun
and Budman, 2005). Thus, tics naturally wax and wane throughout childhood and
adolescence, peaking around age twelve, regrettably at the same time as the natural selfdoubts of the teen years. In addition to their long-term variability, tics are further exacerbated
by anxiety, stress, and excitement (Findley et al., 2003; Leckman et al., 2006a). This makes a
new school year, a timed test, and, ironically, a family vacation to Disney World, prime causes
of tic intensification. For unknown reasons, tics mysteriously and overwhelmingly resolve in
adulthood (Leckman et al., 1998). By age 18, over 90% of children with TS will experience
near resolution of tic symptoms (Goetz et al., 1992; Bloch et al., 2006). Figure 1.1 illustrates
the variable, tiered course of TS into adulthood. While the future extent of TS symptom
severity and complexity is unpredictable at diagnosis, one study found caudate brain volume in
childhood inversely correlated with tic severity in adulthood (Bloch et al., 2005).

Comorbidities
To make matters worse, many children with Tourette Syndrome also have concurrent,
or comorbid, conditions. In fact, one report found only 40% of TS patients do not have a
comorbidity (Denckla, 2006). Attention deficit hyperactivity disorder (ADHD) occurs in over
50% of children with TS (Comings and Comings, 1985). As the name denotes, ADHD results
in developmental inappropriate hyperactivity, inattention, and impulsivity that may persist into
adulthood. As a chief source of dysfunction, ADHD is a major clinical concern (Spencer et al.,
2001) and often disrupts social and academic capacity more than tics do (Mostofsky et al.,
2001). Another comorbidity, obsessive compulsive disorder (OCD) occurs in about 30% of
children with TS (Comings and Comings, 1985). OCD introduces distressing, intrusive, and
unwanted thoughts and fears (e.g., worry of an intruder), resulting in ritualized actions or
thoughts done to relieve anxiety or distress (e.g., repeatedly checking a locked door). Other
less common comorbidities include learning difficulties (e.g., dyslexia), anxiety disorders (e.g.,
social anxiety), affective disorders (e.g., depression or mania), pervasive developmental
disorders (e.g., Asperger’s syndrome), and aggressive behavior. Comorbid disorders may
develop at any time, but are most likely and numerous in early adolescence, mimicking the
progression of tic severity. These comorbidities introduce confusing heterogeneity into the
syndrome phenotype and further disable children with TS from focusing and performing well at
school and home.

6

Table 1.2 Spectrum of severity of tics
Feature

Mild

Moderate

Severe

Duration

Acute, brief

Intermediate length

Tics status

Motor tics

Simple

Complex

Vocal tics

None

Variety of tics

Few

Suppressible

Easily

Interference with life’s

No

activities

disruption

Poorly audible
noises
Multiple
With concentrated
volition
Mildly disruptible

Copropraxia, echopraxia, selfmutilation
Loud noises, coprolalia

Many

No

Highly disruptible

From Fahn S. The clinical spectrum of motor tics. In: Friedhoff AJ and Chase TN. Gilles de la
Tourette Syndrome. Advances in Neurology. Philadelphia: Lippincott Williams & Wilkins;
1982; 35:341-344. Reprinted with permission.
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Figure 1.1 Course of Tourette Syndrome
At diagnosis around age 7, it is unknown whether a given child with Tourette Syndrome
will follow a mild or severe trajectory of symptoms. Tic severity and comorbidities (concurrent
disorders) increase throughout adolescence but overwhelmingly resolve by age 18 in about
90% of patients. Figure adapted from Ian J. Butler, M.D.
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TS is closely intertwined with ADHD and OCD. Symptoms of ADHD often appear
between 3-5 years of age, before tic onset at age 6, and are followed by OCD symptoms up to
a few years later (Bloch et al., 2005). While Pauls and colleagues proposed there are two
types of ADHD, one independent of and another implanted in TS, Towbin and Riddle suggest
all TS patients have some degree of ADHD symptomatology – subthreshold in some patients
and above threshold for ADHD diagnosis in others (Robertson, 2000). The intimate
relationship between TS and OCD is confirmed by historical (e.g., Meige and Feindel, 1907),
epidemiological (e.g., Comings and Comings, 1985), phenomenological (e.g., Pitman et al.,
1987), genetic (e.g., Pauls et al., 1986a), and neuroanatomical evidence (e.g., Rauch et al.,
2001). Specifically, whereas OCD occurs in only 1-3% of the general population, OCD in TS
patients is much more prevalent. Also, the symptoms of both TS and OCD patients wax and
wane and include compulsive tics like touching, counting, and “evening-up.” Critically, TS,
ADHD, and OCD share the common feature of aberrant inhibition of unwelcome thoughts and
behaviors, underscoring the related clinical features and likely analogous neural circuitries of
each disorder.

Etiology and Genetics
Several cited risk factors of TS include prenatal and perinatal adverse events,
psychosocial stressors, and post-infectious immune responses. Much controversy surrounds
the last (Kurlan and Kaplan, 2004), which proposes that abnormal response to streptococcal
infection may lead to onset or exacerbation of neuropsychiatric disorders (Swedo et al., 1998).
One type, pediatric autoimmune neuropsychiatric disorders associated with streptococcal
infection (PANDAS), has a similar phenotype as TS and OCD, and is proposed to develop
through a process called molecular mimicry. Antibodies in response to streptococcal antigens
cross-react with brain targets (e.g., anti-basal ganglia antibodies, Rizzo et al., 2006; but see
Singer et al., 2005 and Morris et al., 2009) and lead to neuropsychiatric disorders. Only
recently did a large case-control study definitively show no strong association between
streptococcal infections and neuropsychiatric syndromes (Schrag et al., 2009).
Many family members of TS patients have transient tics (15-20%) or TS (10-15%) at
rates significantly higher than in controls (Pauls et al., 1991; Eapen et al., 1993; Walkup et al.,
1996; Hebebrand et al., 1997). Even in Gilles de la Tourette’s original description of TS he
noted that three of the nine patients had relatives with tics, and attributed TS to hereditary
factors. Over a century later, geneticists are still in agreement with Gilles de la Tourette’s
limited data, but still have not yet pinpointed a TS gene(s) or inheritance pattern.
9

Chromosomal rearrangement studies have reported rearrangement (Donnai, 1987; Brett et al.,
1996; Devor and Magee, 1999), translocation (Boghosian-Sell et al., 1996; Cuker et al., 2004),
de novo duplication (Kroisel et al., 2001), and inversion (Abelson et al., 2005) on various
chromosomes, but without clear association with TS. Candidate gene studies, which identify
deviations in genes coding for proteins implicated in the disease of interest, have resulted in
negative or equivocal results (Pauls, 2001). Genome-wide linkage studies are used in complex
disorders to search for rare mutations in affected families, but such large pedigrees are hard to
assemble and have not found strong evidence for linkage in TS (Pauls et al., 1990; Pakstis et
al., 1991; Walkup et al., 1996). The most successful studies have been in twins. Monozygotic
twins (identical genomes) are 50-70% concordant for TS, whereas dizygotic twins (50% genes
shared) are only 9% concordant for TS (Price et al., 1985; Hyde et al., 1992). Thus,
monozygotic twins have a many-fold times greater risk to both have TS, indicating multiple
genes constitute a risk of TS. Furthermore, because the rate of TS in monozygotic twins is not
100%, environmental factors must have considerable contribution to the disease (Keen-Kim
and Freimer, 2006).
The strength of conclusions drawn from genetic studies is severely limited by the
heterogeneity of TS. Uncertainty in how to best describe the TS phenotype hampers attempts
to link genes to a given trait (Keen-Kim and Freimer, 2006). Consequently, a new method,
such as the one presented in the current study, is needed to assist categorization of patients
with homogenous symptoms before genetic studies begin.

Pathophysiology
TS was long thought to be purely a psychiatric disorder, and even as late as the 1960s
literature discussed the psychological causation of tics. Margaret Mahler posited that tics
developed following a three-stage process triggered by overprotective and restrictive parents
and solidified by the child’s revolt (Mahler, 1949). In truth, TS is firmly neurologically based,
and only a few decades ago the dopamine hypothesis was established after the first reports of
pharmacologic response to neuroleptics (dopamine antagonists; Bockner, 1959) and tic
exacerbation after high dopamine agonist doses. Neurochemical measurements further
substantiated the role of dopamine and serotonin, as abnormal levels of these neurotransmitter
metabolites were found in the cerebral spinal fluid (Butler et al., 1979), blood (Leckman et al.,
1984; Cath et al., 2001), and urine (Bornstein and Baker, 1988) of TS patients.
While the exact pathophysiology of TS is unknown, loci of dopamine and serotonin
interaction are prime candidates. Neurochemical, neuroanatomical, and neurophysiological
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evidence points to involvement of the basal ganglia (e.g., Peterson et al., 2003; Cheon et al.,
2004; Houeto et al., 2005; Kalanithi et al., 2005), frontal cortex (e.g., Peterson et al., 1998; Moll
et al., 1999; Stern et al., 2000; Peterson et al., 2001; Fredericksen et al., 2002), and distinct
neural circuitry interconnecting the two.
The basal ganglia, comprised of several subcortical nuclei, control and program
movements, activating the desired action and inhibiting all inappropriate alternatives (Figure
1.2, cf., Hallett, 1993; Mink, 1996). The subthalamic nucleus (STN) and striatum (caudate and
putamen nuclei) are the input structures to the basal ganglia. Both receive excitatory,
glutamatergic projections from the cortex, although the “hyperdirect” pathway to the STN is
exclusively from the frontal cortex (Hartmann-von Monakow et al., 1978), whereas all cortical
areas project to the striatum (Kemp and Powell, 1970). This cortical input is topographically
organized (parallel), yet broad dendritic trees accept input from multiple cortical areas
(convergence) and a given cortical area projects to several striatal zones (divergence; Selemon
and Goldman-Rakic, 1985). Further, each cortical projection synapses onto a dendritic spine
head of medium spiny neurons in the striatum (Bouyer et al., 1984; Cherubini et al., 1988),
while the dopamine-containing substantia nigra pars compacta (SNpc) phasically projects onto
the shaft of the same spine (Carpenter, 1981). This anatomic framework allows the striatum to
transform and integrate incoming signals for action selection.
Ultimate basal ganglia output depends on the class of dopamine receptor activated in
the striatum. Two classes of dopamine receptors have been described – the D1 class (D1 and
D5 receptors) and the D2 class (D2, D3, and D4 receptors; Sibley et al., 1993) – and each class
produces an opposite effect. D1 receptors in the striatum send focused inhibitory GABA
projections to the basal ganglia output structures, the globus pallidus internus (GP i) and
substantia nigra pars reticulata (SNpr; Gerfen and Young, 1988; Gerfen et al., 1990). This
“direct/go” pathway serves to inhibit the basal ganglia’s tonic inhibitory output, releasing distinct
thalamic regions to activate their cortical targets and thus generate discrete desired action(s).
In parallel with the “direct/go” pathway, activated striatal D2 receptors phasically send GABAergic inhibitory signals to the globus pallidus externa (GPe; Gerfen and Young, 1988; Gerfen et
al., 1990), which in turn disinhibits the subthalamic nucleus (STN) through GABA-ergic
inhibitory projections (Kita et al., 1983). The STN tonically sends quick, divergent
glutamatergic excitation to the GPi/SNpr (Brotchie and Crossman, 1991; Rinvik and Ottersen,
1993). This “indirect/stop” pathway, together with the “hyperdirect” pathway, serves to provide
widespread excitation to the basal ganglia’s tonic inhibitory output, further clamping down the
thalamus and preventing cortical initiation of diverse, undesired actions. Taken together, the
“direct/go” and “indirect/stop”/”hyperdirect” pathways work in delicate “push-pull” concert to
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Figure 1.2 Basal ganglia circuitry
The frontal cortex sends excitatory, glutamatergic signals to the STN (the “hyperdirect”
pathway), whereas all cortical regions send such signals to the striatum. The striatum
additionally receives dopaminergic projections from the SNpc, activating D1 or D2 striatal
receptors. D1 receptors directly inhibit the GPi/SNpr interrupting its tonic inhibitory GABA-ergic
output to the thalamus, releasing the thalamus to authorize a cortically directed action (the
“direct/go” pathway). Conversely, by inhibiting GPe and disinhibiting STN, D2 receptors
indirectly reinforce GPi/SNpr inhibitory output, obstructing the thalamus from activating an action
(the “indirect/stop” pathway). Shaded boxes comprise the basal ganglia, green projections are
excitatory; red are inhibitory, dotted lines are phasic, solid lines are tonically active. SC,
superior colliculus; see text for other abbreviations.
12

disinhibit (and thereby select) the precise suitable response and maintain inhibition on (and
thus prevent) the myriad, undesired alternatives, respectively.
In addition to motor control, the basal ganglia are involved in the control of a variety of
functions including cognition, emotions, and learning. The basal ganglia control these functions
through five parallel basal ganglia-thalamocortical loops (Alexander et al., 1986). In each loop,
discrete areas of the cerebral cortex project to certain basal ganglia nuclei, which send
information to specific thalamic nuclei and terminate on originating cerebral structures unique to
that loop. The information in each circuit is topographically organized. While the loops are
structurally and functionally segregated, the operations processed at each level of one circuit
are analogous to that of the others. Hence, an abnormality measured at one level in a basal
ganglia-thalamocortical circuit may indicate dysfunction at the same level of other loops
(Alexander et al., 1986).
Specifically, the five basal ganglia-thalamocortical loops include the Motor, Oculomotor,
Dorsolateral Prefrontal, Lateral Orbitofrontal, and Anterior Cingulate circuits (see Figure 1.3
and Figure 1.4). The Motor Loop, which provides motor control, begins in motor cortices,
projects to the putamen, onto ventrolateral pallidal segments and caudolateral SN pr, through
the ventrolateral thalamic nucleus, and back to motor cortices. The Oculomotor Loop controls
externally and internally generated eye movements via frontal cortices, caudate, dorsomedial
GPi and ventrolateral SNpr, and ventral anterior and mediodorsal thalamic nuclei. The
Dorsolateral Prefrontal Loop subserves spatial memory, executive function, and attention. It is
comprised of dorsolateral prefrontal cortex (DLPFC), dorsolateral caudate, dorsomedial GP i
and rostrolateral SNpr, and ventral anterior and mediodorsal thalamic nuclei. The Lateral
Orbitofrontal Loop originates in lateral orbitofrontal cortex (LOFC) and includes ventromedial
caudate, dorsomedial GPi and rostromedial SNpr, and ventral anterior and medial dorsal
thalamic nuclei. This Loop supplies inhibitory control and flexibility of response, as ablation of
LOFC in monkeys results in perseveration and reduced capacity for switching between
behavioral sets (Iversen and Mishkin, 1970; Butters et al., 1973). Finally, the Anterior
Cingulate Loop, which is responsible for limbic (i.e., emotional and motivational) processes,
involves the anterior cingulate cortex (ACC), ventral striatum, rostrolateral GPi and rostrodorsal
SNpr, and mediodorsal thalamic nucleus.
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A. Motor Loop

C. Dorsolateral Prefrontal Loop

B. Oculomotor Loop

D. Lateral Orbitofrontal Loop

E. Anterior Cingulate Loop

Figure 1.3 Circuitry of the basal ganglia-thalamocortical loops
Each loop entails distinct subpopulations of cells in cortical, striatal, pallidal, nigral, and
thalamic regions. A. The Motor Loop includes specific motor cortices and the putamen. B. The
Oculomotor Loop involves frontal cortices and the caudate. C. The Dorsolateral Prefrontal
Loop involves the DLPFC and the caudate. D. The Lateral Orbitofrontal Loop includes the
LOFC and caudate. E. The Anterior Cingulate Loop involves the ACC and ventral striatum.
Shaded boxes comprise the basal ganglia, green projections are excitatory, red are inhibitory,
dotted lines are phasic, solid lines are tonically active. See text for abbreviation details.
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Figure 1.4 Anatomy of the basal ganglia-thalamocortical loops
The five parallel basal ganglia-thalamocortical loops originate and terminate in their own
unique cortical areas. Additionally, all loops traverse the same subcortical nuclei, but synapse
on distinct subpopulations of cells. A. Four loops can be seen on the lateral surface of the
brain. The primary (1°) motor cortex is topographically organized (rainbow gradient) and
distinct tics correspond to discrete aberrant cells. B. One loop is visible only in a sagittal view
of the brain. 1º Motor, primary motor cortex; FEF, frontal eye field; DLPFC, dorsolateral
prefrontal cortex; LOFC, lateral orbitofrontal cortex; ACC, anterior cingulate cortex
15

Much evidence supports the dysfunction of the basal ganglia-thalamocortical loops in
TS, ADHD, and OCD. Consistent with motor tics originating in the Motor Loop, cortical thinning
of sensorimotor areas is reported in TS (Sowell et al., 2008). Emotional disturbances and the
occasional obsene nature of gestures and comments (i.e., copropraxia and coprolalia,
respectively) in TS give suggestion of Anterior Cingulate Loop involvement as well (Trimble and
Robertson, 1987). As the hippocampus projects to the ventral striatum (Krayniak et al., 1981;
Kelley and Domesick, 1982), part of the Anterior Cingulate Loop, the involvement of this loop in
TS is further supported by reports of an abnormal hippocampus in children with TS (larger
volume; Peterson et al., 2007; less gray matter; Ludolph et al., 2006). Cortical thinning (Shaw
et al., 2006; Makris et al., 2007) and volumetric abnormalities (Seidman et al., 2006) of DLPFC
and ACC have been reported in ADHD, highlighting the involvement of the Dorsolateral
Prefrontal and Anterior Cingulate Loops in the disease. Finally, smaller LOFC (Rotge et al.,
2009), less activation of LOFC (Chamberlain et al., 2008), and regional cerebral blood flow
abnormalites in LOFC and ACC as measured by single photon emission computed tomography
(Busatto et al., 2001) implicate the Lateral Orbitofrontal and Anterior Cingulate Loops in the
pathophysiology of OCD.
Stated again, the cause of TS is unknown, but likely involves the basal ganglia and
frontostriatal circuits. Several anatomic models of TS exist (for review, see Steeves and Fox,
2008), including one based on the above-described modification of Albin and colleagues’
classic two-circuit model of the basal ganglia (see Figure 1.2; Albin et al., 1989). This early TS
model proposed an imbalance between an overactive “direct/go” pathway, which continues to
release intended movements, and overactive “indirect/stop” and “hyperdirect” pathways, which
fail to inhibit certain involuntary actions (tics). Disparity in other basal ganglia-thalamocortical
loops would lead to unwanted thoughts and behaviors. A recent update to the model proposes
“centre-surround” activation, stressing the focused inhibition of the “direct/go” pathway, and
widespread excitation of the “indirect/stop” and “hyperdirect” pathways on GPi/SNpr output
(Mink, 2001). The “direct/go” pathway serves to create a “centre” of GPi/SNpr inhibition and
consequent excitation of thalamus and cortical motor pattern generators, whereas the
“indirect/stop” and “hyperdirect” pathways produce a “surround” of GPi/SNpr excitation, realized
as thalamic inhibition and halt of cortical motor activity. By way of the multiple basal gangliathalamocortical circuits, pathologic activity in specific striatal neurons could aberrantly inhibit
basal ganglia output topographically, releasing not only distinct, unwanted tics, but also
unwelcome thoughts and behaviors. This pathological activation may be isolated to
subcompartments of the striatum that in a third model have functional relevance to TS (Canales
and Graybiel, 2000). First described by Graybiel and colleagues, striatal regions named
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striosomes stain only lightly for acetylcholinesterase (AChE), whereas the surrounding matrix
stains heavily for AChE (Holt et al., 1997). Matrix afferents come from many cortical areas and
efferents form the “direct/go” and “indirect/stop” pathways to the GPi/SNpr. Striosomal-based
stereotypies observed in stimulant-treated mice lead to the theory that tics may result from
metabolic activity imbalance between the matrix and striosome (Mink, 2001; Saka and
Graybiel, 2003). In a final model of TS, Leckman and colleagues proposed that asynchronous
oscillations of basal ganglia-thalamocortical loops disrupt the tonic inhibitory output of GPi, thus
repeatedly and momentarily releasing the thalamus to excite cortical areas, producing tics
(Leckman et al., 2006c). In support of this, deep brain stimulation (DBS) and lesions of GP i,
thought to disrupt neural firing, ameliorate tics (Houeto et al., 2005; Zhuang et al., 2009).
Intriguingly, single-unit recordings during pallidotomy showed phasic discharge of GPi
correlating with electromyogram (EMG) recordings of intra-operative tics (Zhuang et al., 2009).
The authors proposed GPi activity preceding EMG onset up to 2 seconds might represent
premonitory urges. In a recent update on basal ganglia models, however, action selection (and
therefore improper action release) is proposed to be a function primarily of the cortex, not basal
ganglia, as basal ganglia subunits are tightly influenced by their respective cortical inputs
(DeLong and Wichmann, 2009). Regardless of the model preferred, a continued search is
necessary to clarify the pathophysiology of TS.
TS has baffled and captivated clinicians and researchers for over 125 years. Modern
technologies and theories continue to push the field closer to a pathophysiological and
etiological consensus. The multifarious dimensions of TS, however, befuddle this effort.
Clearer understanding of TS will come after ferreting out the impact comorbidities have on TS
phenomenology and pathophysiology.
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2. Chapter 2

Orienting in TS
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Eye Movements
We make countless eye movements every day, even every minute (three per second!;
Rayner, 1998). We execute different classes of eye movements when we read a book, track a
buzzing mosquito, or spot out our passenger window the telephone poles whizzing by on a
family car trip. These eye movements serve to orient each eye on the same object, effectively
centering the object of interest on our fovea, the retinal location of highest acuity. One
category of eye movements, saccades, quickly foveate an object or location in space with an
abrupt, small, jerky movement. Saccades are further classified as reflexive or voluntary, each
controlled by distinct, well-known, and well-studied neurocircuitry.
Reflexive saccades are stimulus driven, as they occur in response to a peripheral
stimulus. An instinctive glance to a suddenly appearing light is a reflexive saccade. This type
of saccade is generated in a “bottom-up” fashion in that midbrain reflexive control centers
detect the external stimulus and automatically orient the eyes to it. Reflexive saccades are
driven by the superior colliculus (SC, the midbrain saccade generator) as lesion of it alone
results in saccade slowing and a loss of express (fast) saccades (Schiller et al., 1987).
Voluntary saccades are internally driven, dependent on a plan of action informed by
prior information. Intentionally looking away from a suddenly appearing light involves a
voluntary saccade. This “simple” undertaking demands cognitive control, including inhibition,
generation, and working memory. To successfully look away from the light, you must inhibit
saccades to the appearing light, generate a saccade to the opposite point in space, and
remember what you are trying to accomplish. These components require “top-down” control
from the frontal cortex to the SC via the Oculomotor Loop in the basal ganglia (see Chapter 1).
Explicitly, the dorsolateral prefrontal cortex (DLPFC) inhibits inappropriate reflexive saccades
and the frontal eye field (FEF) triggers the generation of planned voluntary saccades (PierrotDeseilligny et al., 2004). Further, the “direct/go” pathway releases the SC to produce a
saccade and the “indirect/stop” pathway prevents SC execution of an eye movement (refer to
Figure 1.2; Hikosaka et al., 2000).
The ability to override a reflexive response in preference of a voluntary one is
contingent on intact frontal brain regions. Patients with frontal cortex lesions have great
difficulty with the antisaccade task in which they must inhibit a reflexive saccade and instead
make a voluntary saccade (Guitton et al., 1985). Based on such patient and
neurophysiological data, the Tonic Inhibition Model asserts frontal cortical areas, subserving
voluntary control, modulate midbrain reflexive control by way of the basal ganglia’s tonic
inhibitory output (Figure 2.1; Sereno, 1992). Indeed, the basal ganglia perform response
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Figure 2.1 Model of reflexive and voluntary orienting
The Tonic Inhibition Model (Sereno, 1992) maintains that voluntary orienting centers in
the frontal lobe (orange oval) activate the basal ganglia to selectively inhibit the midbrain
reflexive orienting center. The midbrain is free to automatically respond to external stimuli. For
voluntary responses, though, frontal control centers modulate midbrain output by triggering the
basal ganglia to select the appropriate response through calculated release of the midbrain
from its tonic inhibition. SC, superior colliculus
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selection through interconnections with the frontal cortex and brainstem (Hikosaka et al., 2000).
Thus, the reflexive control center can respond to external stimuli as needed. To coordinate a
voluntary response, however, frontal cortices inhibit brainstem execution of reflexive actions in
order to delay the intended response until the appropriate time.
This interplay between reflexive and voluntary systems is evident in everyday
examples. When you are walking alone to the parking lot at twilight, a dancing shadow beside
some bushes causes you to instinctively jump. In this unnerving situation, your voluntary
frontal center only lightly impedes reflexive responses, allowing hypervigilance. Alternatively,
when you are rigorously studying in a bustling coffee shop (which, as an aside, I deem
counterproductive regardless the strength of your voluntary control), the sea of people and
vibrant colors don’t even cause you to look up. In this instance, your voluntary center strongly
dampens reflexive responding to allow maintained focus.

Value of Saccade Research
The direct study of saccadic eye movements has great utility. Saccades are a discrete
behavioral method with limited output, measureable with extraordinary precision and influenced
with slight paradigm and sensory changes (Hutton, 2008). Saccadic eye movements and their
neural command have long been studied in non-human primates and lesion patients (Hikosaka
and Wurtz, 1983; Bruce and Goldberg, 1985; Guitton et al., 1985; Pierrot-Deseilligny et al.,
1991; Everling et al., 1999). Also, cortical neuroanatomy of saccade control has been
investigated in healthy adults with intact oculomotor systems by inducing temporary “functional
lesions” with transcranial magnetic stimulation (TMS; Muri and Nyffeler, 2008). Consequently,
the neural circuitry underlying saccades is intimately known.
Compared to traditional psychological testing, eye movement tests are particularly well suited
for evaluating cognitive control and motor processes. First, task instructions are simple and
easily understood by all ages. Second, in eye movement tasks, encoding and response
processes are in the same modality (visual), whereas in typical tasks translation is required
from the stimulus input modality (visual, auditory) to behavior measures (motor, speech), which
dilutes the task’s ability to directly measure the desired cognitive process. Third, eye
movements share brain areas with cognitive control and motor processes (Luna et al., 2004)
and different (and experimentally separable) brain areas control reflexive and voluntary
saccades. Moreover, saccade tasks have been shown to have greater test-retest reliability
than neuropsychological tasks in healthy individuals and patients (Gooding et al., 2004; Hill et
21

al., 2008) and be more sensitive measures of cognitive control (Broerse et al., 2001) and
treatment effects (Hill et al., 2008).
Further, studies of saccades eliminate confounds common to neuropsychological
testing. Neurological and psychiatric patient populations (e.g., Parkinson disease and
schizophrenia) demonstrate slowing in the initiation and execution of manual responses (e.g.,
key press) compared with healthy participants (Benson, 1990; Bermanzohn and Siris, 1992;
Jogems-Kosterman et al., 2001). Psychomotor slowing is specific to manual response tasks
but not eye movement tasks (Gale and Holzman, 2000; Reuter and Kathmann, 2004).
Whereas neuropsychological tests tap broad frontal areas, saccade paradigms exploit known,
distinct regions. Moreover, saccade tasks do not require additional higher order processing,
like for colors, pictures, or words.
Saccade paradigms are particularly effective measures of cognitive control in hard-totest populations, like patients and children. Eye movement tasks allow careful and easy
manipulation of task difficulty and produce robust and sensitive results. Assessment is quick
and avoids fatigue common to such participants. Significantly, hypotheses of a disease’s
neuropathological loci can be appraised by saccade task performance (Farber et al., 1999).
Indeed, patients with frontal cortex and basal ganglia neuropathology exhibit saccadic deficits
(Guitton et al., 1985; Briand et al., 1999). The utility of saccade tasks in patients and children is
demonstrated by successful treatment evaluation (Reilly et al., 2006), prediction of disease
outcome (Robert et al., 2009), utility as an endophenotype (Calkins et al., 2008) and biomarker
(Blekher et al., 2006), and assessment of cognitive development (Luna et al., 2004). Our lab
has extensive experience and success conducting eye movement research in patients and
children. We have demonstrated eye movement performance is linked to schizotypy in healthy
participants (Larrison et al., 2000), correlates with symptom severity (Briand et al., 2001;
Amador et al., 2006; Jeter et al., 2010), evaluates treatment efficacy (Larrison-Faucher et al.,
2004; Hood et al., 2007; Babin et al., in preparation 1), differentiates clinically-defined disease
subtypes (Jeter et al., 2009), and identifies a cognitively-impaired subtype of schizophrenia
(Babin et al., in preparation 2).
In addition to the specific advantages of eye movement studies described above in
neurological and psychiatric patient and child populations, saccade tasks are particularly well
suited for investigations in TS. As a disease characterized not only by release of situationally
unfitting movements and behaviors, but also insufficient generation of pertinent actions, TS
dysfunction is synonymous with misdirected cognitive control. Restated, TS patients have a
specific lack of response inhibition, response generation, and working memory. These faculties
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are also critically employed in voluntary eye movement tasks. Fittingly, common brain areas
instruct cognitive control and voluntary eye movements (Luna et al., 2004). Thus, dysfunctional
cognitive control, measureable with simple saccade paradigms, can be linked to mutual brain
regions. Specifically, the parallel basal ganglia-thalamocortical Motor and Oculomotor Loops
underwrite this relationship (see Chapter 1), making eye movement experiments useful for
understanding how the brain controls movement (Leigh and Zee, 1999). Unlike limb
movements, though, eye movements are simple movements not hindered by joints, muscle
load restrictions, or large ranges of motion, and so are easily measured. Eye movements are
natural, quick, and quantifiable. From decades of non-human primate and lesion patient
research, the neural circuitry controlling saccade generation is better understood (Leigh and
Zee, 1999). While a few research groups have capitalized on the advantages of oculomotor
research in TS, more studies are needed (Rommelse et al., 2008).
Not only are oculomotor tasks poised to effectively evaluate Motor Loop function, but
also they are suitable for appraisal of the other three basal ganglia-thalamocortical loops.
These parallel loops, namely the Dorsolateral Prefrontal Loop, the Lateral Orbitofrontal Loop,
and the Anterior Cingulate Loop, govern spatial working memory and attention, socially
appropriate response lability, and mood stability and motivational drive, respectively. Not
surprisingly, then, irregularity in these loops leads to ADHD and OCD, the conditions most
commonly coexisting with TS. Thus, in conjunction with eye movement investigations of TS
cognitive control, saccade tasks can examine the impact of comorbid ADHD and OCD on
cognitive control in TS patients. Such an endeavor is imperative to quantify and better
understand the specific functional weight TS individuals bear due to comorbid conditions
(Gooding and Basso, 2008; Rommelse et al., 2008). Parceling and attributing the impact of
comorbid ADHD and OCD will create more homogenous subtypes of TS necessary to advance
stymied genetic analyses (Gooding and Basso, 2008).

Model of Orienting in TS
TS patients are known to have abnormal frontal lobe anatomy and function, perhaps in
response to a primary dysfunction of the basal ganglia. As frontal cortices and the basal
ganglia are directly involved in the Oculomotor Loop, these disruptions have immediate
implications for the control of eye movements. According to the model of reflexive and
voluntary orienting in Figure 2.1, frontal deficit leads to poor performance on tasks of voluntary
orienting. Further, a weak frontal cortex reduces its excitation of the basal ganglia, which, in
turn, relents from its tonic inhibitory dominance over the midbrain reflexive control center (SC).
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Thus, performance on reflexive eye movement tasks is normal or even hyper-reflexive. Figure
2.2 details this hypothesized dysfunction in TS. In addition to impacting the SC, reduced basal
ganglia output allows the thalamus to excessively activate the cortex, producing tics.

Previous Eye Movement Studies in TS
Motivated by all the benefits saccadic research affords, the current study employed
behavioral tasks of saccadic response to assay cognitive control in TS. A handful of past
investigations have undertaken this endeavor, but taken together, they have emerged in a
cacophony of contradiction. Reporting findings from a reflexive saccade task, three groups
found normal response times in TS patients (Bollen et al., 1988; Straube et al., 1997; Nomura
et al., 2003), while Farber and colleagues (1999) reported faster response times than controls
and two teams cited slower response times for TS patients (Mostofsky et al., 2001; Munoz et
al., 2002). On eye movement tasks tapping voluntary function, all studies found slower
response times (Straube et al., 1997; Farber et al., 1999; Dursun et al., 2000; Mostofsky et al.,
2001; Munoz et al., 2002; Nomura et al., 2003). On measures of error rate (percent of
responses to an incorrect location), though, two research teams reported increased voluntary
antisaccade errors compared to controls (Farber et al., 1999; Dursun et al., 2000), yet three
others found no significant increase (Straube et al., 1997; Mostofsky et al., 2001; Munoz et al.,
2002).
In only a subset of the oculomotor studies were both reflexive and voluntary tasks
administered, enabling consideration of the results in terms of the underlying anatomical and
functional relationships between reflexive and voluntary control. While frontal cortices reinforce
the basal ganglia’s tonic inhibitory output to block midbrain-mediated automatic responses (see
Figure 2.1), the midbrain reflexive center is allowed to execute automatic responses when
momentarily released from basal ganglia domination. This interchange proffers the prediction
that a deficit in prefrontal activity can result in both deficits in voluntary orienting as well as
decreased inhibition producing normal or hyper-reflexive orienting (see Figure 2.2). Evidence
from Parkinson’s disease patients, as well as other clinical populations across a number of
paradigms, supports this assertion (Sereno and Holzman, 1995; Sereno and Holzman, 1996;
Briand et al., 1999; Larrison et al., 2000). For response time, three studies (Straube et al.,
1997; Farber et al., 1999; Nomura et al., 2003) aligned with the claim that decreased prefrontal
activity in TS (demonstrated by increased voluntary eye movement response time) should
result in decreased inhibition of reflexive orienting mechanisms (revealed in normal or
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Figure 2.2 Model of hypothesized effect of TS on orienting
Normal orienting is achieved when frontal voluntary control centers modulate the
midbrain reflexive center by way of the basal ganglia’s tonic inhibitory output. In TS, known
abnormalities in the frontal cortex lead to impaired voluntary orienting. Further, weak frontal
cortices are lax in properly engaging the basal ganglia to inhibit the reflexive control center. As
a result, reflexive orienting is normal or hyper-reflexive. Similar dysfunction in the Motor Loop
disinhibits the thalamus, allowing excessive excitation of motor actions (tics). 1º Motor, primary
motor cortex; SC, superior colliculus
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decreased reflexive eye movement response time) and two did not (Mostofsky et al., 2001;
Munoz et al., 2002). For error rate, two supported (Farber et al., 1999; Dursun et al., 2000) and
three contradicted the prediction (Straube et al., 1997; Mostofsky et al., 2001; Munoz et al.,
2002). The divergence of results prevents a clear understanding of the biological basis of TS.
How could the findings from these studies be so different? On closer inspection of the
study designs, three aspects emerge as confounding factors. When sufficient regard is not
given to the influence of these factors on oculomotor performance, the conclusions drawn from
a study will be attributed solely to disease effects, when in reality other obstructing factors are
at play (Reilly et al., 2008). Regrettably, most studies did not even consider culprit confounds;
only a few groups performed underpowered post hoc analyses. In the following paragraphs I
will enumerate the complicating factors of medication status, age, and comorbidity in prior eye
movement studies in TS and address why these aspects must be constrained to provide clear
ascertainment of cognitive control in pure TS. Table 2.1 and Table 2.2 catalog each study,
reviewing how study design features obfuscated results.
Medication status is the first confound frequently present in eye movement studies in
TS. Psychiatric medications are known to alter eye movement performance (for review, Reilly
et al., 2008). TS participants were commonly tested while actively taking pharmacological
treatments for their symptoms. Risperidone (dopamine [D2] and serotonin [5HT2A] antagonist)
is a common pharmacotherapy in TS and has been shown to slow reflexive saccade response
time (Sweeney et al., 1997; Nieman et al., 2000). Hence, it is possible TS studies that do not
control for medication may show saccadic response time increases due to medication
differences. For example, one previous study examined performance in risperidone-treated TS
patients and found increased reflexive eye movement response times (Munoz et al., 2002).
Interestingly, risperidone has been shown to decrease antisaccade errors (Burke and Reveley,
2002; Harris et al., 2006). Studies in risperidone-treated TS patients that do not control for
medication may show normal antisaccade error rate (Munoz et al., 2002) that may be due to
medication normalizing an antisaccade deficit in TS. While some groups did attempt to probe
for a drug effect and argued for its absence, such post hoc analyses are known to be
underpowered (Reilly et al., 2008).
A second confound of previous saccade work in TS is age. Not only is controlling for
age important because TS severity changes drastically throughout development and
neurobiological differences exist between children and adults with TS, but also many studies
have documented development of oculomotor function during childhood (Munoz et al., 1998;
Fukushima et al., 2000; Klein and Foerster, 2001; Luna et al., 2004). Reflexive saccade
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Table 2.1 Confounding factors and results of past eye movement studies in TS (I)

ADHD, attention deficit hyperactivity disorder; OCD, obsessive compulsive disorder; y, years;

RT, response time; ER, error rate; + slower or greater than controls; – faster or less than

controls; 0 no difference from controls; SD, standard deviation; N/A, not applicable
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Table 2.2 Confounding factors and results of past eye movement studies in TS (II)

ADHD, attention deficit hyperactivity disorder; OCD, obsessive compulsive disorder; y, years;

RT, response time; ER, error rate; + slower or greater than controls; – faster or less than

controls; 0 no difference from controls; CV, coefficient of variation; N/A, not applicable
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response time is greatly prolonged in 6-7 year olds, but decreases to adult levels by the age of
10-11 years. Studies that do not consider developmental differences in saccade parameters
may report response time increases due to age effects. Most previous studies enrolled adults
or a broad range of ages rather than only children (Straube et al., 1997; Farber et al., 1999;
Dursun et al., 2000; Munoz et al., 2002). Only two studies have considered oculomotor
development (Mostofsky et al., 2001; Nomura et al., 2003); one found increased reflexive
response time in participants less than 10 years old. Again, there are also important
developmental changes in antisaccade error rates. Antisaccade error rate decreases to near
adult levels around age 16 (Munoz et al., 1998; Fukushima et al., 2000; Klein and Foerster,
2001). Only one prior study considered an age effect on antisaccade errors and found more
errors in those less than 10 years old than those older than 10 years (Mostofsky et al., 2001).
Comorbid status is the final confound present in past oculomotor studies in TS. Most
TS patients have a concurrent pathology, or comorbidity, such as ADHD or OCD, which may
impact eye movement findings. In point of fact, multiple eye movement studies in children with
ADHD alone report increased reflexive response time variability (Mostofsky et al., 2001; Munoz
et al., 2003) and increased antisaccade response time and errors compared to controls (Klein
et al., 2003; Munoz et al., 2003; Karatekin, 2006). Only one study has been conducted in
children with OCD alone and compared to controls found increased antisaccade errors and
anticipatory errors in a memory-guided task (Rosenberg et al., 1997). Four prior studies in TS
did not consider the impact of concomitant conditions (Bollen et al., 1988; Straube et al., 1997;
Dursun et al., 2000; Nomura et al., 2003). Of the three studies that did, Farber and colleagues
(1999) hinted at differing performance in TS subpopulations. This study reported that while TS
antisaccade errors were significantly increased compared to controls, the increased errors
were from a subset comprising 19% of the patients. Straube and colleagues (1997) also
reported increased antisaccade errors, but the large error rate variability suggests
subpopulations. Only Mostofsky and colleagues (2001) controlled for ADHD and found TS
patients with ADHD had greater prosaccade response time and response time variability, more
antisaccade errors, and more anticipatory saccades during the delay period of a memory
saccade task compared to patients with only TS. This pattern of results suggests TS patients
with a comorbidity display unique, separable results (and underlying pathophysiology) from
patients with only TS. Also to be considered, age effects may occur in comorbid populations.
Only one study considered this in TS patients with ADHD and found a significant interaction
between age and diagnosis (Mostofsky et al., 2001).
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Current Study
The goal of my study was to obtain an accurate saccadic measure of cognitive control
in unmedicated children with TS and assess the influence of comorbid conditions. Further, this
study improved upon prior work in this field by controlling for medication status, age, and
comorbid conditions known to have produced conflicting results. These precautions ensured
my observed outcomes were a direct reflection of TS pathology, not study confounds. First, to
avoid diverse impacts of medications on eye movement performance, I included only
unmedicated TS patients. Such patients are not rare. Family members are often more
troubled by TS than the patient and because symptoms wax and wane in severity, initiating
educational interventions and lifestyle adjustments before jumping to medications is best
(Swain et al., 2007). Second, this study limited enrollment to children 10-16 years old. The
age of peak tic severity occurs in this age range (Leckman et al., 1998; Bloch et al., 2006). At
ten years old most visual functions stabilize and become adult like (Klein and Foerster, 2001),
cerebral blood flow to frontal lobe grey matter reaches adult patterns (Ogawa et al., 1989), and
right hemisphere fronto-temporal/occipital EEG coupling becomes evident (left coupling occurs
earlier; Thatcher et al., 1987). Around age 16, antisaccade error rate decreases to near adult
levels (Munoz et al., 1998; Fukushima et al., 2000; Klein and Foerster, 2001). Therefore, I
restricted enrollment to this smaller age range and carefully selected each control participant to
be within six months of age of one or more TS patients. Thirdly, this study compared two
subsets of TS patients, individuals with TS only and those with TS and comorbid ADHD and/or
OCD. Thus, largely unhindered by medication, age, or comorbidity, this unique, carefully
controlled study directly measured aspects of cognitive control.
I used traditional reflexive and voluntary saccade tasks to evaluate orienting in TS.
These tasks included the reflexive Prosaccade task (automatically look to a peripheral target
when it appears), and the voluntary Antisaccade task (deliberately look opposite the suddenly
illuminated target). I also created variants of the spatial N-back task – the 0-back task (look to
the last stimulus in a variable series of flashes) and 1-back task (look to the next-to-last
stimulus in a variable series of flashes). Versions of these N-back tasks were extensively pilot
tested in healthy adults and children (Jeter et al., submitted). The design is scalable for
difficulty, producing robust results regardless of the number of stimuli or possible stimulus
locations. Whereas the Prosaccade is a control task, the Antisaccade, 0-back, and 1-back
tasks are powerful measures of response inhibition, response generation, and working
memory. These tasks require the same processes that allow proper execution of body
movements and are thought to be dysfunctional in TS. In addition to suppression of automatic
and early responses (like withholding tics), these tasks require remembering and generating
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voluntary eye movements at the proper time to a specific non-illuminated location (voluntarily
generating a proper non-tic action). Performance of TS patients, broken down by TS children
with or without comorbid ADHD and/or OCD, was compared to typically developing children.
The research plan and hypotheses for these comparisons are detailed in the next sections.
In addition to evaluating cognitive control in TS, my study will verify a couple cognitive
theories. First, are reflexive and voluntary functions really inversely related in TS as current
models hold (i.e., inadequate volitional control produces normal or hyper-reflexive responses;
see Figure 2.2)? Independent or positively related, rather than inversely related, results from
reflexive and voluntary eye movement tasks would necessitate revision of this cognitive model.
Second, do multiple aberrant basal ganglia-thalamocortical loops coincident with TS and
implicated in the cause of comorbid ADHD and OCD (see Chapter 1) induce worse eye
movement performance? If TS patients with comorbid conditions perform poorly compared to
individuals with TS only, such a contention is upheld.

Research Plan Part 1: Classic Oculomotor Tasks
The goal of the current study, to obtain an accurate saccadic measure of cognitive
control in children with TS and assess the influence of comorbid conditions, was completed in
two parts. First, basic reflexive and voluntary orienting in TS patients was assessed with
classic oculomotor tasks. As detailed above, past evaluations of reflexive and voluntary eye
movement performance in TS has produced mixed results. When tested with reflexive,
Prosaccade tasks, TS patients have demonstrated slow reflexive responses (Mostofsky et al.,
2001; Munoz et al., 2002) and normal reflexive responses (Bollen et al., 1988; Straube et al.,
1997; Farber et al., 1999; Nomura et al., 2003). So, too, on Antisaccade tasks of voluntary
function, TS patients have shown increased errors (Farber et al., 1999; Dursun et al., 2000)
and normal error rates (Straube et al., 1997; Mostofsky et al., 2001; Munoz et al., 2002). Any
attempt at deducing the biological truth from these disparate results, although valiant, is
grasping at straws. Even if a composite view is proposed, such a model of TS is undeniably
influenced by medication, age, and/or comorbid status and thus is not representative of the
pure disease. Critically, then, this study probes TS reflexive and voluntary eye movement
performance while controlling for confounding factors.
I expected unmedicated TS patients without concomitant ADHD or OCD to exhibit
impaired voluntary orienting and normal or heightened reflexive orienting (i.e., prolonged
response time and increased errors on an Antisaccade task and normal or faster Prosaccade
response times). This hypothesis follows from the model of orienting in TS depicted in Figure
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2.2. Because of involvement of additional basal ganglia-thalamocortical loops, I expected
those TS patients with comorbid ADHD and/or OCD to display even more exaggerated
voluntary orienting yet largely normal reflexive orienting (i.e., slower response times and more
errors on an Antisaccade task than healthy control children or patients with TS only). Indeed,
children with only ADHD have slower response times and increased errors on Antisaccade
tasks compared to healthy control children (Klein et al., 2003; Munoz et al., 2003; Karatekin,
2006). Children with OCD also have more Antisaccade errors than typically developing
children (Rosenberg et al., 1997). Increasingly impaired voluntary function in TS patients with
comorbid conditions points to pathophysiology additional to that of individuals with TS only.
Thus, in an extended model of orienting in TS (see Figure 2.3), overlay of defective basal
ganglia-thalamocortical circuits representing TS, ADHD, and OCD results in progressively
weaker frontal voluntary control and diminished basal ganglia output.

Research Plan Part 2: Novel Spatial N-back Tasks
The second part of the current study was to evaluate childhood cognitive control in TS
and its comorbidities using a variant of the spatial N-back task (Callicott et al., 1998). The Nback task is a working memory task in which participants must continually revise and update
their mental set with each subsequent stimulus in order to properly respond to a specific
previously presented stimulus. N-back tasks allow working memory load to be adjusted for
difficulty, as higher N requires more stimuli to be held in mind (e.g., the 0-back task requires
response to the current stimulus, the 1-back task requires response to the previous stimulus,
etc.). While most spatial and non-spatial N-back tasks are runs of continually appearing
stimuli, my novel version was designed in blocks of discrete trials. This enabled all stimuli to be
identical squares (rather than numbers, for example) differentiable only by location, duplicating
the Prosaccade and Antisaccade task stimuli. Participants completed N-back tasks of two
levels of difficulty, 0-back and 1-back, suitable for a child patient population (Jeter et al.,
submitted).
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Figure 2.3 Model of hypothesized effects of comorbidities and TS on orienting
Normal orienting is achieved when frontal voluntary control centers modulate the
midbrain reflexive center by way of the basal ganglia’s tonic inhibitory output. In TS,
dysfunction in the Motor Loop disinhibits the thalamus, allowing excessive excitation of motor
actions (tics). Comorbid conditions in TS arise likewise from additional pathology of other basal
ganglia thalamocortical loops. Each successive Loop abnormality leads to further impaired
voluntary orienting. Weak frontal cortices diminish the basal ganglia’s inhibition of the reflexive
control center. As a result, reflexive orienting is normal or hyper-reflexive. 1º Motor, primary
motor cortex; FEF, frontal eye field; DLPFC, dorsolateral prefrontal cortex; LOFC, lateral
orbitofrontal cortex; SC, superior colliculus
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While no group has tested TS patients on saccadic spatial N-back tasks, a select few
have administered saccadic working memory tasks. Unfortunately, research groups did not
report the same dependent variables, preventing complete comparison of results. In the
Memory Guided task, participants must look to a remembered location at the appropriate time.
Straube and colleagues (1997) found normal response time, whereas Nomura and colleagues
(2003) found slower response time. Nomura and colleagues (2003) also reported fewer
distracted saccades in children with TS, and Mostofsky and colleagues (2001) were able to
identify this increase specifically in TS patients with ADHD compared to those with TS alone.
More similar to spatial N-back tasks, the Sequential Memory task requires participants to
maintain fixation on a central light during a sequence of peripheral flashes. Munoz and
colleagues (2002) reported increased anticipatory errors in TS patients.
As with the Antisaccade task, which also tested voluntary function, I expected
unmedicated patients with TS alone to exhibit impaired cognitive control on these voluntary
tasks (i.e., prolonged response time and increased errors on both N-back tasks). Furthermore,
compared to healthy age-matched peers, I expected children with TS only to perform even
more poorly on the 1-back task than the 0-back task, as the former entails greater working
memory load. Because of involvement of additional basal ganglia-thalamocortical loops, I
expected the voluntary performance of TS patients with comorbid ADHD and/or OCD to be
even more lacking (i.e., slower response times and more errors on both N-back tasks than
healthy controls or patients with TS only).
Highlighting deficits on tasks demanding working memory, children with only ADHD
have slower response times (Mostofsky et al., 2001) and increased anticipatory errors (Ross et
al., 1994; Castellanos et al., 2000; Mostofsky et al., 2001; Rommelse et al., 2008) on Memory
Guided tasks, which, like N-back tasks, require a delayed response to a remembered target.
Compared to normal controls, children with OCD tend to have more anticipatory errors on
Memory Guided tasks (Rosenberg et al., 1997). One study of children with TS and
concomitant ADHD reported increased anticipatory errors compared to children with TS only
(Mostofsky et al., 2001). This result supports the model of orienting for TS patients with
comorbidities (Figure 2.3), contending that the additional impaired basal gangliathalamocortical circuits representing TS, ADHD, and OCD result in progressively weaker frontal
voluntary control.
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Research Plan Part 3: Factor Analysis
As a third focus, I undertook an endeavor to reduce this study’s many variables into
meaningful factors, each comprised of related dependent variables. Two factor analyses were
completed. The first created factors explaining the variance in the eye movement response
time and error rate variables. The second divided the variance in the totals and subscales of
three diagnostic rating scales administered to assess symptoms of TS, ADHD, and OCD.
Both factor analyses are novel to the literature. Very few studies have analyzed eye
movement variables by factor analysis, and then only Prosaccade and Antisaccade tasks
(Fischer et al., 1997; Klein and Foerster, 2001; Fischer et al., 2000). Factor analyses of clinical
symptoms are much more common, often in the creation or validation of a diagnostic rating
scale (Conners et al., 1998; Storch et al., 2005; Storch et al., 2006). These factor analyses of
symptoms, however, have not assessed multiple diagnostic rating scales at once. Such a test
would provide insight into the interrelatedness of frequently co-occurring disorders.
I expected the eye movement variables to divide into factors representing reflexive and
voluntary processes (i.e., a Prosaccade factor and an Antisaccade, 0-back, and 1-back factor).
In previous factor analyses of eye movement tasks, variables from the reflexive Prosaccade
task loaded a different factor than variables from a voluntary Antisaccade task in both healthy
participants (Fischer et al., 1997; Fischer et al., 2000; Klein and Foerster, 2001) and those with
dyslexia (Fischer et al., 2000). As each disorder is comprised of a common constellation of
symptoms, I expected some diagnostic rating scale factors to represent a single scale, with the
possibility of other factors representing a potpourri of mixed subscales.
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3. Chapter 3

Methods
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Study Participants
Before testing, each participant’s parent or guardian gave informed consent and as
children, each participant gave assent. The University of Texas Health Science Center at
Houston Committee for the Protection of Human Subjects approved the study consistent with
the Declaration of Helsinki.
Patients
TS patients were recruited through The University of Texas Child and Adolescent
Neurology Clinic without bias for gender or ethnicity. Patients were diagnosed with TS based
on the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders – Fourth
Edition (DSM-IV). Dr. Ian J. Butler, a pediatric neurologist and TS expert, performed
independent evaluations of each TS patient, including clinical history and neurological
examination to ensure each patient met the study inclusion criteria.
• Inclusion Criteria for TS Group
1. Diagnosis of TS based on DSM-IV diagnostic criteria
2. Aged 10-16 years
3. Normal (or corrected-to-normal) vision
• Exclusion Criteria for TS Group
1. Tic disorder (did not meet TS diagnostic criteria) or psychogenic tics
2. Unable or unwilling to wean off neurological or psychiatric medications in order
to be medication-free one week prior to testing
3. (a) Other active medical or major psychiatric disorders except ADHD or OCD,
(b) substance abuse, (c) history of electroconvulsive therapy, (d) neurosurgery,
(e) history of head injury, or (f) brain tumor or infection
Controls
Control participants were recruited from the community by Institutional Review Boardapproved flyers and a listing on The University of Texas Health Science Center at Houston
Clinical Trials website. The control group was not case-matched to TS patients, but rather
each control participant was matched by gender and within 6 months of age to 2 or 3 TS
patients. Thus, the control group had an equivalent gender ratio and similar age mean and
standard deviation as TS patients (see Results, Table 4.1).
• Inclusion Criteria for Control Group
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1. Aged 10-16 years
2. Normal (or corrected-to-normal) vision
• Exclusion Criteria for Control Group
1. Diagnosis of a neurological or psychiatric condition
2. Currently using neurological or psychiatric medications
3. Sibling or parent with an active neurological or psychiatric disorder
4. (a) Substance abuse, (b) history of electroconvulsive therapy, (c) neurosurgery,
(d) history of head injury, or (e) brain tumor or infection

Diagnostic Measures
Dr. Butler assessed TS patients in the clinic as described above. In the experimental
session, diagnostic rating scales were administered to assess disease state and symptom
severity of each child. All participants (TS patients and Controls) and their parent(s) or
guardian independently completed the diagnostic rating scales. As an expert rater, I also
evaluated each participant. My ratings of each child only differed from the participant’s selfreport value when the rating was obviously contrary to behavior I observed during the two-hour
testing session. Thus, for two diagnostic scales, each participant had three scores, one each
from the participant, parent(s) or guardian, and me. On the scale assessing OCD symptoms,
only the participant and parent(s) or guardian values were used, as I did not know each child
well enough to accurately evaluate his or her internal obsessions and daily compulsions, and
these would not fully be evident in a two-hour testing session. The diagnostic rating scales are
available in Appendix A and the group means for these measures are in the Results, Table
4.1. Scales always were administered in the same order and after eye movement tasks.
• Attention Deficit Hyperactivity Disorder Rating Scale – IV (ADHD-IV; DuPaul et al.,
1998): This self-report scale is a reliable measure to assess childhood and adolescent
attention and behavior deficits. ADHD-IV subscales include inattention and
hyperactivity.
• Obsessive Compulsive Inventory – Child Version (OCI-CV; Foa et al., 2010): All
participants completed this self-report inventory as a measure of obsessive-compulsive
characteristics. Derived from the adult OCI, the OCI-CV authors revised and simplified
the inventory to be well suited for a child population. OCI-CV subscales addressed
obsessing, washing, hoarding, doubting/checking, neutralizing, and ordering.
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• Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989): This self-report version
of the YGTSS rated number, frequency, intensity, complexity, and interference of motor
and phonic tics separately and impairment combined. The correlation between the selfreport and clinician versions of the YGTSS is r = 0.86, p < 0.0001 (Leckman et al.,
1994b).

General Procedure
All aspects of experimental design were optimized for use in a child patient population.
Testing sessions were scheduled at each family’s convenience, usually on a Saturday. Under
the guidance of Dr. Ian Butler, their pediatric neurologist, willing TS patients on neurological or
psychiatric medications (12 of 39 patients) were placed on an individualized weaning schedule.
This ensured each patient had a proper washout period of at least one week prior to testing.
Behavioral testing (eye movement tasks) and diagnostic rating scales were completed
in The University of Texas Medical School at Houston. All participants (except one very wiggly
10-year-old boy) were tested on one day. The wiggly boy completed three of the four eye
movement tasks and all diagnostic rating scales during our first testing session. At the second
testing session three and a half weeks later, he completed the one remaining eye movement
task and repeated the diagnostic rating scales. For analysis, the self-report, parent, and expert
diagnostic rating scale scores from his two testing sessions were averaged.
During each testing session, consent was obtained from the parent(s) or guardian and
assent from child participants. A background questionnaire (see Appendix A) was completed
to gather information on first-degree relatives with schizophrenia, bipolar disorder, or other
psychiatric, neurological, or developmental disorders. Further questions inquired about
previous diagnoses (including streptococcus, implicated as a risk factor), medications, and
nicotine or caffeine intake, as these substances are known to possibly affect eye movements.
Patients and parent(s) or guardian also reported age at first tic onset, age of diagnosis, types of
motor and vocal tics from childhood to the present, when tics most likely occur, how patients
knew a tic was about to happen, and whether and for how long patients could suppress tics.
Following informed consent, assent, and background questionnaire completion,
parent(s) or guardian waited in an adjacent room and completed three diagnostic rating scales
to assess the child participant on symptom severity. Child participants completed the
behavioral testing followed by the diagnostic rating scales. All participants also agreed to give
a saliva sample for proteomic analysis, in collaboration with Pramod Dash, Ph.D., and future
correlation with behavioral measures.
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Eye Movement Tasks
Overview
Extensive pilot testing guaranteed the eye movement tasks were simplified as much as
possible (Jeter et al., submitted). Each task took between 5 and 15 minutes to complete, with
all tasks completed within one hour, including breaks. The brevity of the tasks and ample
breaks ensured that even the youngest and most inattentive child was not fatigued. I used
white stimuli on a black screen so potential color vision deficiencies would not be a factor
(Melun et al., 2001). Each task was devised to test specific cognitive processes. An important
element of task design was that each task required the same response (a vertical or horizontal
saccade). Thus, any performance differences among groups could be ascribed to an aspect of
cognitive control, not to a change in sensory or motor control. One task was designed as a
control to verify equivalent sensorimotor control in TS and control children.
Prosaccade
In this task (Figure 3.1), participants simply looked to a stimulus that appeared
randomly in one of four peripheral locations. The Prosaccade task served as a control task,
verifying that sensory-input (stimulus) and motor-output (an eye movement of a specified
amplitude) processes were intact.
The computer screen was black (25.3° x 19.5° of visual field; 0.32 cd/m2) with a central
grey fixation circle (0.2° diameter; 28.04 cd/m2) surrounded by four open boxes (1.1° x 1.1°;
28.04 cd/m2) placed in cardinal directions (north, south, east, and west), 7° eccentric to the
central fixation point. The open boxes at potential target locations served as landmarks to
increase the spatial accuracy of participant saccades (Briand et al., 2001; Karatekin, 2006).
Stimuli were filled white boxes (0.2 x 0.2°; 156.61 cd/m2), which could appear in one of the four
landmark boxes. An eye movement was recorded when both areal and velocity criteria were
met:
•

Fixation Window: A region 5.8° in diameter was centered over the fixation point.
Fixation was maintained if the participant’s current eye position was determined to be
within in this window.

•

Target Window: A region 4.2° in diameter was centered over each landmark (target
location). Saccades to the target were considered correct if they terminated in this
region.

•

Velocity Criteria: Initiation of an eye movement was indicated by velocity above 18.0°/s
and the end was indicated by velocity below 4.6°/s.
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Figure 3.1 Prosaccade task
See text for task procedure details. Correct response is an upward saccade.
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Specifically, participants were instructed to fixate on a central fixation point and make a
speeded, accurate saccade to the peripheral target when it appeared. To initiate each trial,
participants had to first fixate the central fixation point for 400 ms (Figure 3.1A). Next, a
peripheral target appeared simultaneously with the offset of the central fixation point (Figure
3.1B); this is called a step paradigm, as the target appears to step outward from the fixation
point. Finally, the participant made a saccade to the peripheral target. The Prosaccade task
comprised of 8 practice trials and 48 task trials with equal target presentation in each of the
four landmarks. Each trial was classified and recorded based on the participant’s eye
movement response and saved in a file.
•

Break in Fixation: If an eye movement was made before target presentation, the trial
was aborted, recorded as a discarded trial, and added to the trial pool to be represented in random order.

•

Correct: If an eye movement was initiated after target presentation and ended in the
correct Target Window, it was recorded as a correct trial. Trial details (response time,
duration, gain [i.e., spatial accuracy], and eye position coordinates sampled every 4 ms)
were recorded.

•

Error: If an eye movement was made after target presentation and it ended anywhere
but inside the correct Target Window, it was recorded as an error trial. Trial details
(response time, duration, gain, and eye position coordinates sampled every 4 ms) were
recorded. Visual feedback (“wrong place”; 24 point font, 28.04 cd/m2) was presented
just below the fixation point.

•

Timeout: For the first 28 patients and 8 controls, if an eye movement was not made
within 1492 ms of target presentation, the trial was aborted, recorded as a timeout, and
added to the trial pool to be re-presented in a random order. Once I discovered the
timeout parameter was mistakenly this long, I reduced the setting such that subsequent
participants had 906 ms after target presentation to complete an eye movement. This
change was made to reduce the number of discarded trials, as trials with response
times longer than 900 ms were trimmed from analysis. Visual feedback (“too slow”; 24
point font, 28.04 cd/m2) was presented just below the fixation point and auditory
feedback (double tone, 45 then 44 Hz) was presented.
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Antisaccade
In this task (Figure 3.2), participants inhibited the reflexive impulse to look to the
peripheral stimulus and instead voluntarily generated an eye movement to the opposite
landmark. This task tested the participants’ cognitive control.
The computer screen, “Fixation Window,” “Target Window,“ and “Velocity Criteria”
settings were identical to those for the Prosaccade task.
Specifically, participants were directed to fixate on the central fixation point and make a
speeded, accurate saccade directly opposite a peripheral stimulus when it appeared.
Participants fixated the central fixation point for 400 ms to initiate each trial (Figure 3.2A).
Next, a peripheral target appeared simultaneously with the offset of the central fixation point
(Figure 3.2B); again, this is called a step paradigm, as the target appears to step outward from
the fixation point. Lastly, the participant completed an eye movement to the stimulus’s mirror
location on the opposite side of the screen. The Antisaccade task comprised of 8 practice trials
and 48 task trials with equal target presentation in each of the four landmarks.
The “Break in Fixation,” “Correct,” “Error,” and “Timeout” parameters were identical to
those in the Prosaccade task.
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Figure 3.2 Antisaccade task
See text for task procedure details. Correct response is an upward saccade.
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0-back
In this task (Figure 3.3), participants observed a series of sequential stimulus flashes,
each in a different location and made a saccade to the remembered location of the last, or 0back, stimulus. This task was a classic test of working memory.
The computer screen, “Fixation Window,” “Target Window,“ and “Velocity Criteria”
settings were identical to those for the Prosaccade task.
Specifically, participants were told to fixate on the central fixation point throughout a
succession of flashes occurring (without location repeat) in the four peripheral landmarks.
Once the fixation point disappeared, participants were to make a quick and accurate saccade
to the last flash of the remembered sequence. To initiate a trial, participants first had to fixate
the central fixation point for 750 ms (Figure 3.3A). While participants kept their eyes on the
fixation point, 2 or 3 white, square stimuli appeared in sequence, each in a unique landmark.
Stimuli appeared for 80 ms with a 350 ms interstimulus interval (ISI) between each stimulus
(Figure 3.3B-D). The participants continued to fixate during a 500 ms delay until the central
fixation point was extinguished (Figure 3.3E). This served as the “go signal,” at which the
participants made a saccade to the remembered location of the last, or 0-back, stimulus, be it
the second of two or third of three flashes in the sequence (Figure 3.3F). The random
presentation of two or three stimuli per trial (each in 50% of the trials) prevented participants
from using predictive strategies to time the initiation and direction of the saccade. The 0-back
task comprised of 8 practice trials and 96 task trials with equal final stimulus presentation in
each of the four landmarks. Every participant saw the same 96 trials of stimulus sequences, as
the trials were run from a file of pre-generated random sequences.
Inherently, an N-back task first requires the subject to remember N+1 locations at once,
and second to update those locations – dropping the old one and remember the new – while
retaining the presentation order of each. This second demand to actively manipulate the
information in mind crucially differentiates the N-back task as a measure of working memory
rather than short-term memory, as the latter only requires memory on a short time-scale. Such
delayed response task measures of working memory critically rely on the prefrontal cortex
(Barch et al., 1997).
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Figure 3.3 0-back task
See text for task procedure details. Correct response is an upward saccade. The
ellipsis after the fixation screen denotes the omission of an additional stimulus and ISI
occurring on 50% of the trials. The possibility of an additional stimulus prevented participants
from predicting the timing and direction of their saccades. ISI, interstimulus interval
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Each trial was classified based on the participant’s eye movement response and saved in a file.
•

Discarded: If an eye movement was made at an improper time, such as before offset of
the fixation point, the trial was aborted, recorded as a discarded trial, and added to the
trial pool to be re-run in a random order. Trial details (locations of sequence stimuli,
final eye position, type of discard, time point in trial of discard, and eye position
coordinates sampled every 4 ms) were recorded. Discarded trials were further
classified based on when the saccade was made.
1. Break in Fixation: If an eye movement was made before stimulus presentation,
the trial was aborted, recorded as a fixation break, and added to the trial pool to
be re-run in random order.
2. Disinhibition: If an eye movement was made after the first stimulus, but before
the offset of the fixation point, the trial was aborted, recorded as a discarded
trial, and added to the trial pool to be re-run in a random order. Trial details
(time point in trial of eye movement and 10 eye position coordinates sampled
every 4 ms) were recorded.
3. Timeout: For 28 patients and 8 control participants, if an eye movement was not
made within 1492 ms of target presentation, the trial was aborted, recorded as a
timeout, and added to the trial pool to be re-run in a random order. However,
once this long timeout parameter was discovered, the setting was changed such
that subsequent participants had 906 ms after target presentation in which to
make an eye movement. This change was made to reduce the number of
discarded trials after trimming trials with latencies longer than 900 ms. Visual
feedback (“too slow”; 24 point font, 28.04 cd/m2) was presented just below the
fixation point and auditory feedback (double tone, 45 then 44 Hz) was
presented.

•

Correct: If an eye movement was made after offset of the fixation point and it ended in
the correct Target Window, it was recorded as a correct trial. Trial details (response
time, duration, gain, and eye position coordinates sampled every 4 ms) were recorded.

•

Error: If an eye movement was made after offset of the fixation point and it ended
anywhere but inside the correct Target Window, it was recorded as an error trial. Trial
details (response time, duration, gain, and eye position coordinates sampled every 4
ms) were recorded. Visual feedback (“wrong place”; 24 point font, 28.04 cd/m2) was
presented just below the fixation point.
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1-back
In this task (Figure 3.4), participants observed a series of sequential stimulus flashes,
each in a different location, and made a saccade to the remembered location of the next-tolast, or 1-back, stimulus. This task was a classic test of working memory.
The computer screen, “Fixation Window,” “Target Window,“ and “Velocity Criteria” were
identical to those for the Prosaccade task.
Specifically, participants were told to fixate on the central fixation point throughout a
succession of flashes occurring (without location repeat) in the four peripheral landmarks.
Once the fixation point disappeared, participants were to make a quick and accurate saccade
to the next-to-last flash of the remembered sequence. Trial events and timing proceeded
identically to those in the 0-back task, with the exception that when the central fixation point
disappeared, participants made a saccade to the remembered location of the next-to-last, or 1back, stimulus, be it the first of two or second of three flashes in the sequence (Figure 3.4F).
Again, the random presentation of two or three stimuli per trial (each in 50% of the trials)
prevented participants from using predictive strategies to time the initiation and direction of the
saccade. The 1-back task comprised of 8 practice trials and 96 task trials with equal next-tolast stimulus presentation in each of the four landmarks. Every participant saw the same 96
trials of stimulus sequences, as the trials were run from a file of pre-generated random
sequences.
Critically, the 1-back task required participants to continually update their mental set by
holding the two most recent locations in mind – exchanging the earliest presented for the most
recent stimulus – all while remembering presentation order. In comparison to the 0-back task,
which required memory of and response to only the most recent stimulus, the 1-back task
demanded greater working memory load as correct response necessitated maintaining two
locations and presentation orders in active memory storage.
The “Discarded,” “Correct,” and “Error” parameters were identical to those in the 0-back
task.
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Figure 3.4 1-back task
See text for task procedure details. Correct response is an upward saccade. The
ellipsis after the fixation screen denotes the omission of an additional stimulus and ISI
occurring on 50% of the trials. The possibility of an additional stimulus prevented participants
from predicting the timing and direction of their saccades. ISI, interstimulus interval
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Task Counterbalance
The four eye movement tasks described above were semi-counterbalanced. The Nback working memory tasks were always completed first, and the basic orienting tasks were
completed second. This ensured the children completed the lengthy tasks (in trial duration and
number of trials) first, leaving the shorter tasks (again, in trials and trial duration) as a fresh
surprise and motivator to maintain cooperation and attention. Both TS and healthy control
children were assigned a counterbalance order in this rotation, respectively:
•

0-back, 1-back, Prosaccade, Antisaccade

•

0-back, 1-back, Antisaccade, Prosaccade

•

1-back, 0-back, Prosaccade, Antisaccade

•

1-back, 0-back, Antisaccade, Prosaccade

Behavioral Testing Procedure
Following parental/guardian informed consent, child participant assent, and completion
of the background questionnaire, families were introduced to the entire experimental set-up
(Figure 3.5A) and procedures. Then, families departed to rest in the adjacent waiting room
(Figure 3.5B), which was filled with kid-friendly décor and toys, perfect for accompanying
siblings and participant breaks. Testing room lights were turned off and participants were
allowed to dark-adapt as they were seated in a (non-rolling, non-swiveling!) chair and fitted in
the chin rest (Figure 3.5C). Each task (“games,” as called for the kids’ benefit) began with an
explanation of rules and example trials acted out on a printed page of the basic task screen.
Participants could ask questions both before and after a set of practice trials, which could be
repeated, to ensure each child understood the rules before continuing with the experimental
trial block. Because trials were self-paced, participants were encouraged to rest their eyes or
sit back from the chin rest, as trials only continued when the eye tracking camera detected the
participant’s gaze at the fixation point on the monitor.
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Figure 3.5 Eye tracking set-up
A. From left, participant chair and chin rest, eye-tracking monitor/computer, participant
flat screen monitor on far side of divider wall, Macintosh computer with custom programs,
experimenter seat and monitor. B. Comfortable space with fun toys and popular chalkboard.
C. From left, stimulus screen, ISCAN® camera, and example volunteer on chin rest.
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Eye Movement Measurement
Each participant was seated 72 cm from the center of a computer screen in a dark room
with his/her head held in place by a chin rest and forehead restraint. Stimuli were presented on
a monitor (LCD, 17 inch, 75 Hz refresh rate, 1024 x 768 pixels) connected to a Power G4
Macintosh computer running OS 9 operating system. An infrared eye-tracking camera
(ISCAN® ETL-200, Burlington, Massachusetts) measured eye movement of the right eye. The
eye-tracker, connected to the Macintosh via a USB port, pinpointed the participant’s pupil and
corneal reflection of infrared rays. Using the spatial difference of these two points, which
changed as the participant looked around the screen, the ISCAN® equipment could calculate
eye position at 240 Hz regardless of small shifts in head or body position. Consequently,
further restraint of a participant’s head was not needed and childhood squirming or the tics of
TS did not affect the measurements. A custom program developed using commercially
available software (Vision Shell; Code Warrior) was used to present visual stimuli and record
details of eye movements. For each trial in all experiments, the eye position data were
analyzed online, automatically canceling trials with invalid eye movements and later representing them in random order.
Before each eye movement task, the participant was instructed to look at nine points on
the screen. Corresponding eye position coordinates were recorded. Throughout the task,
custom calibration software used these reference points to calculate the x- and y-axis screen
coordinates of the participant’s pupil (with an error radius about 0.25°).
Dependent Measures
For each task, two files per participant were saved. The data file recorded specific trial
types, timing of precise screen events, and classification of each trial’s result (as described
above). The x- and y-axis eye position coordinates from every 4 ms sample for each trial were
saved in a separate file. Online control of the experiments (e.g., aborting a trial) was enabled
by measures calculated from these values. The files were also available for offline analysis
(see Appendix B for sample outputs). Dependent measures common to each task include:
•

Response Time: This was the elapsed time from when the fixation point disappeared
until the saccade began, also known as latency. Meeting both areal (gaze outside the
Fixation Window) and velocity (movement above 18.0°/s) criteria marked the initiation of
a saccade.

•

Error Rate: This was the percentage of trials in a task in which the participant made an
eye movement at the correct time, but to an incorrect location.
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•

Working Memory Load: This was a measure of working memory demand on a
participant, calculated as the difference in response time or error rate for the 1-back and
0-back tasks. A positive working memory load indicated a greater demand on working
memory in the 1-back task. This measure pertained only to the 0-back and 1-back
tasks.

•

Disinhibition: This was a measure of inhibition and was a count of the number of Nback discarded trials in which the participant made an eye movement after the first flash
but before the “go signal.” This measure pertained only to the 0-back and 1-back tasks.

Data Analysis
Customized programming scripts in MATLAB 7.3 for Mac (Mathworks) compiled and
averaged each participant’s data file from each task. First, trials with a response time less than
100 ms or greater than 900 ms were discarded. From the remaining trials, error rate was
calculated as the percentage of trials in which the participant made an eye movement to an
incorrect location. Correct trials were further trimmed if response time was 2.5 standard
deviations from the participant’s mean. Mean response time was calculated from these
remaining trials.
The MATLAB output and clinical measures were combined in a PASW Statistics 17.0
for Mac (formerly SPSS) spreadsheet for subsequent analyses. Pearson’s correlations (twotailed) compared the symptom severities of TS, ADHD, and OCD. Those patients with an OCICV score greater than 2.33 standard deviations above the mean control participant score
and/or an ADHD-IV percentile rank above 85 were classified as TS-comorbid patients. Raw
response time and error rate of each behavioral task and working memory load were included
in separate multivariate linear models with TS status (Control, TS-only, TS-comorbid) as a main
factor, adjusting for age as a covariate, to assess planned contrasts. Because of a non-normal
distribution, disinhibitions from the 0-back and 1-back tasks were included in a Poisson
loglinear Generalized Linear Model with TS status as the main factor and age as a covariate to
evaluate planned contrasts. Response time and error rate of each behavioral task and working
memory load were included in a factor analysis and factors with eigenvalues over one
extracted. Totals and subscales of the three diagnostic rating scales were included in another
factor analysis and again factors with eigenvalues over one extracted. Pearson’s partial
correlations (controlling for age) compared each of the eye movement factors to each of the
diagnostic rating scale raw totals and diagnostic rating scale factors.
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4. Chapter 4

Results
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Control and Tourette Syndrome Participants
Twenty-nine typically developing children (Controls) and thirty-nine children with TS
completed all diagnostic rating scales and eye movement tasks. The age and gender
composition of the two participant groups are listed in Table 4.1 and did not statistically differ
from one another (gender: t66 = 0.55, p = 0.59; age: t66 = 0.29, p = 0.77). Three raters per
participant independently completed self-report diagnostic rating scales of ADHD (Attention
Deficit Hyperactivity Disorder Rating Scale-IV, ADHD-IV), OCD (Obsessive Compulsive
Inventory – Child Version, OCI-CV) and TS (Yale Global Tic Severity Scale, YGTSS) to assess
symptom severity of the child. For the ADHD and TS scales, every participant had three
scores, one each from the participant, parent(s) or guardian, and me. On the scale assessing
OCD symptoms, only the participant and parent(s) or guardian values were used, as I did not
know each child well enough to accurately evaluate his or her internal obsessions and daily
compulsions, whereas I could assess the severity of external hyperactivity, inattention, and tics.
Mean scores of these scales are also listed in Table 4.1. As expected, Controls and children
with TS differed statistically on all scale ratings (ADHD-IV: t66 = -6.44, p < 0.001; OCI-CV: t60 =
-7.24, p < 0.001; YGTSS: t39 = -12.60, p < 0.001).
To identify any relationship between symptom severities of TS, ADHD, and/or OCD,
individual patient diagnostic rating scale scores were plotted against one another in pairs.
Scatter plots of these three comparisons are shown in Figure 4.1 (ADHD-IV vs. OCI-CV),
Figure 4.2 (ADHD-IV vs. YGTSS), and Figure 4.3 (OCI-CV vs. YGTSS). Interestingly, patient
scores on all three diagnostic rating scales correlated with one another. Patient scores of
ADHD symptoms correlated strongly with OCD symptoms (ADHD-IV vs. OCI-CV: r(38) = 0.53,
p < 0.001) and moderately with TS symptoms (ADHD-IV vs. YGTSS: r(38) = 0.22, p = 0.17).
Ratings of patient OCD symptoms significantly correlated with TS symptoms (OCI-CV vs.
YGTSS: r(38) = 0.35, p = 0.03). Thus, as symptoms of one disorder increase, so do symptoms
of the other two. This indicates that not only are ADHD and OCD strongly related to one
another in TS, but also that these comorbid conditions are inherent in TS, not additional to the
disorder as classically thought. Further, this indicates ADHD and OCD symptoms are present
at some level in most all TS patients. Only ADHD and OCD diagnostic rating scale scores
correlated among Controls; the other scale pairings were not significant (ADHD-IV vs. OCI-CV
r(28) = 0.42, p = 0.02; ADHD-IV vs. YGTSS r(28) = 0.05, p = 0.80; OCI-CV vs. YGTSS r(28) =
0.34, p = 0.07).
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Table 4.1 TS and Control demographics and diagnostic rating scale scores
Gender
Control
Tourette
Syndrome

19 M, 10 F

28 M, 11 F
p = 0.59

Age

ADHD-IV

OCI-CV

YGTSS

13.16 (2.10)

43.3 (24.3)

3.9 (2.6)

0.7 (1.3)

[10.19-16.54]

[0-84.0]

[0-9.5]

[0-3.7]

13.01 (2.11)

78.3 (20.4)

10.8 (5.1)

36.0 (17.5)

[10.09-16.95]

[28.4-98.9]

[3.0-22.0]

[9.3-95.0]

p = 0.77

p < 0.001

p < 0.001

p < 0.001

Gender: M = male, F = female. All values are mean (standard deviation) [range]. Age is in
years. ADHD-IV, Attention Deficit Hyperactivity Disorder Rating Scale-IV (percentile rank 1100); OCI-CV, Obsessive Compulsive Inventory – Child Version (score range 0-42); YGTSS,
Yale Global Tic Severity Scale (score range 0-100).
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Figure 4.1 TS and Control ADHD and OCD symptom severity
Individual TS patient and Control ADHD-IV percentile ranks are plotted against OCI-CV
total scores. Dotted lines indicate the cutoff scores above which participants are classified as
having ADHD or OCD. ADHD-IV, Attention Deficit Hyperactivity Disorder Rating Scale-IV; OCICV, Obsessive Compulsive Inventory – Child Version
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Figure 4.2 TS and Control ADHD and tic symptom severity
Individual TS patient and Control ADHD-IV percentile ranks are plotted against YGTSS
global (total) scores. Dotted line indicates the cutoff score above which participants are
classified as having ADHD. ADHD-IV, Attention Deficit Hyperactivity Disorder Rating Scale-IV;
YGTSS, Yale Global Tic Severity Scale
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Figure 4.3 TS and Control OCD and tic symptom severity
Individual TS patient and Control OCI-CV total scores are plotted against YGTSS global
(total) scores. Dotted line indicates the cutoff score above which participants are classified as
having OCD. OCI-CV, Obsessive Compulsive Inventory – Child Version; YGTSS, Yale Global
Tic Severity Scale
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Control and Tourette Syndrome Participants Divided by Comorbid Status
For a classification of comorbid ADHD, children must have ranked above the 85th
percentile on the ADHD-IV total score, which is the standard per the ADHD-IV manual.
Because I used the OCI-CV while its authors still were determining a cutoff score, I set a value
based on the Controls in my study. A classification of OCD was given when a child scored
2.33 standard deviations above the mean of the Controls. This deviance value represents 2%
of the population, which is the prevalence of childhood OCD (Zohar, 1999). In the last section,
I showed that the symptom severities of TS, ADHD, and OCD correlated with one another. So,
all children with TS who scored above the cutoffs for ADHD and/or OCD were assigned to a
TS-comorbid group, while those below the cutoffs for ADHD and OCD were considered to have
only TS (TS-only). As tic severity correlates with ADHD and OCD symptom severity, the
nomenclature of TS-only and TS-comorbid more precisely refers to an overall less and more
severe profile, respectively. No control child scored above the ADHD or OCD cutoffs.
Table 4.2 lists the demographics and diagnostic rating scale scores of the same
Controls and TS patients, the latter now divided into eighteen TS-only children and twenty-one
TS-comorbid children. These three groups did not differ statistically by gender or age (gender:
F(2,65) = 1.19, p = 0.31; age: F(2,65) = 0.05, p = 0.95), but a higher proportion of females were TScomorbid patients than males (8/11 girls compared to 13/28 boys). Naturally, the three groups
differed on the diagnostic rating scale scores (ADHD-IV: F(2,65) = 37.00, p < 0.001; OCI-CV:
F(2,65) = 53.91, p < 0.001; YGTSS: F(2,65) = 61.84, p < 0.001). Controls differed significantly from
TS-only patients (ADHD-IV: p = 0.001; OCI-CV: p = 0.002; YGTSS: p < 0.001) and TScomorbid patients (ADHD-IV: p < 0.001; OCI-CV: p < 0.001; YGTSS: p < 0.001). TS-comorbid
children were rated significantly more severe than TS-only children on all but tic severity
(ADHD-IV: p < 0.001; OCI-CV: p < 0.001; YGTSS: p = 0.11).
Age is known to affect eye movement performance (Fukushima et al., 2000; Klein and
Foerster, 2001; Munoz et al., 1998; Luna et al., 2004), which is why this study not only
excluded adults, but also limited the juvenile participant ages to between 10 and 16 years
(discussed in Chpt. 2, Orienting in TS). Yet, as shown in Figure 4.4A and B, younger
participants, regardless of disease status, had significantly increased response times and more
errors (higher error rate) on voluntary eye movement tasks such as the Antisaccade task
(response time: r(67) = -0.28, p = 0.02; error rate: r(67) = -0.61, p < 0.001). Thus, in all
analyses of eye movement variables, age was entered as a covariate to eliminate its influence
on the behavioral data.
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Table 4.2 TS subtype and Control demographics and diagnostic rating scale scores
Gender
Control

19 M, 10 F

TS-only

15 M, 3 F

TS-comorbid

13 M, 8 F
p = 0.31

Age

ADHD-IV

OCI-CV

YGTSS

13.16 (2.10)

43.3 (24.3)

3.9 (2.6)

0.7 (1.3)

[10.19-16.54]

[0-84.0]

[0-9.5]

[0-3.7]

12.95 (2.24)

63.1 (20.1)

7.2 (2.0)

32.3 (13.3)

[10.18-16.95]

[28.4-84.9]

[3.0-10.0]

[9.3-67.7]

13.06 (2.06)

91.5 (7.7)

13.9 (4.9)

39.2 (20.2)

[10.09-15.98]

[75.0-98.9]

[5.0-22.0]

[18.3-95.0]

p = 0.95

p < 0.001

p < 0.001

p < 0.001

Gender: M = male, F = female. All values are mean (standard deviation) [range]. Age is in
years. See text for planned comparisons between group diagnostic rating scale scores.
ADHD-IV, Attention Deficit Hyperactivity Disorder Rating Scale-IV (percentile rank 1-100); OCICV, Obsessive Compulsive Inventory – Child Version (score range 0-42); YGTSS, Yale Global
Tic Severity Scale (score range 0-100).
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A. Response Time

B. Error Rate

Figure 4.4 Voluntary eye movement performance across age
A. Response times and B. errors on a voluntary eye movement task decrease with age.
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Part 1: Classic Oculomotor Tasks – Prosaccade and Antisaccade
The first part of this study employed the Prosaccade and Antisaccade tasks, two
traditional measures of orienting, to assess reflexive and voluntary functioning, respectively.

Prosaccade Task
Response Time
For each participant, trials with a response time less than 100 ms or greater than 900
ms were discarded. Correct trials were further trimmed if response time was 2.5 standard
deviations from the participant’s mean. Mostofsky and colleagues used a similar procedure
(Within a task, response times ≤115 ms were trimmed. Additional trials were trimmed if they
were 2 standard deviations from the mean response time of the task; Mostofsky et al., 2001).
Mean response time was calculated from these remaining correct trials. Controls, TS-only
patients, and TS-comorbid patients did not differ from one another on Prosaccade response
time (F(2,64) = 0.27, p = 0.78; Figure 4.5A).

Error Rate
From trials remaining after the initial trim (response time less than 100 ms or greater
than 900 ms), error rate was calculated as the percentage of trials in which the participant
made an eye movement to an incorrect location. Controls, TS-only patients, and TS-comorbid
patients had comparable Prosaccade task error rates (F(2,64) = 1.56, p = 0.22; Figure 4.5B).
Only when all TS patients were combined did they marginally have more errors than Controls
(p = 0.08).
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A. Response Time

B. Error Rate

Figure 4.5 Prosaccade task response time and error rate
A. Response Time. B. Error Rate plotted on y-axis for comparison to subsequent
tasks. Inset below plotted to visualize group differences. All TS patients combined marginally
had more errors than Controls.
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Antisaccade Task
Response Time
Mean Antisaccade response time for each participant was calculated in the same way
as for the Prosaccade task and differed among the groups (F(2,64) = 2.83, p = 0.07). TScomorbid patients took significantly longer to respond than TS-only patients (p = 0.02), whose
performance was comparable to Controls (p = 0.29; Figure 4.6A). Controls and TS-comorbid
patients did not differ in time to respond (p = 0.13).

Error Rate
Antisaccade error rate was calculated in the same way as for the Prosaccade task.
Antisaccade error rate nearly differed among groups (F(2,64) = 1.76, p = 0.18). TS-comorbid
patients marginally had more errors on the Antisaccade task than Controls (p = 0.07). TS
patients combined, regardless of comorbid condition, also showed a statistical trend for more
errors than Controls (p = 0.09; Figure 4.6B). Counter to expected results, Control and TS-only
patients had equivalent Antisaccade error rates (p = 0.28).
Because increasing tic severity is associated with increasing severities of ADHD and
OCD symptoms (Figure 4.2 and Figure 4.3), and TS patients with increased severities of
these comorbid conditions tended to have more errors than Controls on the voluntary
Antisaccade task (Figure 4.6B), I next completed an exploratory analysis to determine whether
TS-only patients with high tic severity had increased Antisaccade errors compared to TS-only
patients with low tic severity or Controls. Using the median tic severity of the TS-only group
(YGTSS = 31.83) as the cutoff, I divided the TS-only patients into higher (TS-only Higher, n =
9) and lower (TS-only Lower, n = 9) tic severity groups. The groups did differ on Antisaccade
error rate (F(2,43) = 3.37, p = 0.04). Amazingly, TS-only Higher patients had a significantly
greater Antisaccade error rate than TS-only Lower patients (p = 0.03) or Controls (p = 0.02;
Figure 4.7). In contrast, TS-only Lower patients had a similar Antisaccade error rate as
Controls (p = 0.81).
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A. Response Time

B. Error Rate

Figure 4.6 Antisaccade task response time and error rate
A. Response Time. Patients with comorbid conditions were significantly slower to
respond than patients without comorbid conditions. B. Error Rate. TS-comorbid patients, as
well as all TS patients combined, had marginally more errors than Controls.
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Figure 4.7 Antisaccade task error rate for TS-only patients with lower and higher tic severity
While TS-only patients with lower tic severity (TS-only Lower) continued to perform
comparably with Controls, TS-only patients with higher tic severity (TS-only Higher) not only
had significantly more errors than Controls, but also more errors than TS-only patients with
lower tic severity (TS-only Lower).
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Part 1 Summary
These data support the hypothesis that TS patients with comorbid conditions have weak
voluntary control in comparison to Controls and patients with TS only. TS-comorbid patients
had slowed voluntary responding (Antisaccade response time; Figure 4.6A) compared to TSonly patients. Intimating weak voluntary inhibition, TS-comorbid patients tended to have an
elevated Antisaccade error rate compared to Controls (Figure 4.6B). Unexpectedly, TS-only
patients did not show any voluntary deficits compared to Controls.

Part 2: Novel Spatial N-back Tasks – 0-back and 1-back
In the second part of this study the 0-back and 1-back tasks, novel measures of spatial
working memory, were administered to assess components of voluntary function, specifically
response inhibition, response generation, and working memory.

0-back Task
Response Time
Each participant’s mean 0-back response time was calculated as described in the
Prosaccade task response time section. Controls, TS-only patients, and TS-comorbid patients
did not differ from one another on 0-back response time (F(2,64) = 0.03, p = 0.97; Figure 4.8A).

Error Rate
Each participant’s error rate for the 0-back task was computed as described in the
Prosaccade error rate section. 0-back error rate differed across the three groups (F(2,64) = 6.08,
p = 0.004). TS-comorbid patients not only had a significantly higher 0-back error rate than
Controls (p = 0.002), but they also had a significantly higher 0-back error rate than TS-only
patients (p = 0.006; Figure 4.8B). Again, TS-only patients surprisingly had comparable error
rate performance to Controls (p = 0.98). When all children with TS were grouped, they showed
a marginally greater 0-back error rate than Controls (p = 0.07).
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A. Response Time

B. Error Rate

Figure 4.8 0-back task response time and error rate
A. Response Time. B. Error Rate. TS-comorbid patients not only had significantly
more errors than Controls, but also more errors than TS-only patients. Additionally, all TS
patients combined had marginally more errors than Controls.
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1-back Task
Response Time
Mean 1-back response time for each participant was calculated using the same
procedure as for the Prosaccade task. Groups marginally differed on 1-back response time
(F(2,64) = 1.95, p = 0.15). TS-comorbid patients tended to have increased 1-back response time
compared to Controls (p = 0.09) and TS-only patients (p = 0.09; Figure 4.9A). TS-only
patients responded in similar time as Controls (p = 0.81).

Error Rate
1-back error rate was calculated in the same way as for the Prosaccade task. Controls,
TS-only patients, and TS-comorbid patients had similar 1-back error rate (F(2,64) = 1.39, p =
0.26; Figure 4.9B).

Working Memory Load
Working Memory Load is the added demand placed on working memory by the 1-back
task compared to the 0-back task. Response time or error rate Working Memory Load is
quantified by subtracting the 0-back task performance from that of the 1-back task. A positive
value denotes more working memory load in the 1-back task compared to the 0-back task.

Response Time
Working Memory Load mean response time was computed by subtracting each
participant’s mean 0-back response time from mean 1-back response time. There were
differences among the groups (F(2,64) = 2.71, p = 0.07). TS-comorbid patients not only took
significantly longer to respond in the 1-back task than 0-back task compared to Controls (p =
0.04), but also longer than TS-only patients (p = 0.05; Figure 4.10A). As in all other tasks, TSonly patients did not differ from Controls (p = 0.91).

Error Rate
Working Memory Load error rate was computed by subtracting each participant’s 0back error rate from 1-back error rate. Controls, TS-only patients, and TS-comorbid patients
did not differ on Working Memory Load error rate (F(2,64) = 0.09, p = 0.92; Figure 4.10B).
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A. Response Time

B. Error Rate

Figure 4.9 1-back task response time and error rate
A. Response Time. TS-comorbid patients responded in marginally more time than
Controls or TS-only patients. B. Error Rate.
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A. Response Time Difference

B. Error Rate Difference

Figure 4.10 Working Memory Load response time and error rate difference
A. Response Time Difference between 1-back and 0-back tasks. Working Memory
Load response time difference was significantly greater for TS-comorbid patients than for
Controls or TS-only patients. B. Error Rate Difference between 1-back and 0-back tasks. RT,
response time; ER, error rate

72

N-back Task Disinhibitions
0-back and 1-back response time and error rate were calculated only on trials when
participants properly maintained fixation throughout the delay period (see Methods, Figure 3.3
and Figure 3.4). Trials in which participants made an early eye movement in response to a
mid-trial stimulus flash were considered disinhibitions. While disinhibitions were tallied and
saved in a file, these trials were rerun and did not count toward the 96 total trials in a testing
block.
The distribution of the number of disinhibitions was non-normal in both N-back tasks for
Controls, TS-only patients, and TS-comorbid patients. Thus, the data were analyzed using a
Poisson loglinear Generalized Linear Model with age as a covariate. For the 0-back task, all
participant groups had equivalent disinhibitions (Wald Chi-Square(2, 64) = 1.94, p = 0.38; Figure
4.11A). For the 1-back task, however, the effect of group was significant (Wald Chi-Square(2, 64)
= 12.67, p = 0.002). Whereas TS-only patients had marginally more disinhibitions than
Controls (p = 0.08), TS-comorbid patients had significantly more disinhibitions than Controls (p
< 0.001; Figure 4.11B). TS-only and TS-comorbid patients did not differ (p = 0.11).

Part 2 Summary
TS-comorbid patients continued to demonstrate poor voluntary control in comparison to
Controls and patients with TS only. Not only did TS patients with comorbid conditions have
increased 0-back errors compared to Controls, but also TS-only patients (Figure 4.8B). Had
TS patients not been subdivided by comorbidity, this significant difference would have been
masked as a trend, falsely attributing inhibitory deficits to all TS patients, regardless of
comorbid status. As in Part 1, TS-only patients countered my hypothesis and showed no
voluntary deficits in comparison to Controls. A tendency for TS-comorbid patients to respond
more slowly than Controls or TS-only patients in the 1-back task (Figure 4.9A) was significant
for Working Memory Load in both cases (Figure 4.10A). TS-comorbid patients also made
more disinhibitions in the 1-back task than Controls (Figure 4.11B).
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A. 0-back

B. 1-back

Figure 4.11 0-back and 1-back task disinhibitions
A. 0-back task disinhibitions. B. 1-back task disinhibitions. TS-comorbid patients had
significantly more early eye movements to mid-trial stimuli (disinhibitions) than Controls. TSonly patients tended to have more disinhibitions than Controls.
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Part 3: Factor Analysis – Eye Movement Variables and Rating Scale Totals/Subscales
In the final part of this study, factor analyses served to 1) reduce my data into fewer,
meaningful components that capture the majority of the variance within my original variables
and 2) detect structural relationships and explain the pattern of correlations among variables.
In a factor analysis, each subject is plotted in an n-dimensional space where n represents the
number of original variables. A line most closely passing through all data points, and thus
accounting for as much variance as possible, is drawn through this space. The extent to which
each axis (original variable) correlates with this first factor is its loading strength. Another line
(factor) is drawn that accounts for the majority of the remaining variance and is orthogonal to
(uncorrelated with) the first factor. This process is reiterated until all variance is accounted for.

Eye Movement Variables
To determine if the many eye movement variables could be reduced into meaningful
factors that also represent the structural relationships between variables, presumably reflecting
brain organization, I conducted a factor analysis of the response time and error rate measures
from all four eye movement tasks and working memory load. A variable was considered to
have loaded a factor if its correlation (loading) with the factor was greater than r = 0.45. Table
4.3 lists the four factors extracted, the amount of variance for which they accounted, and the
eye movement variables represented by each factor and at what rotated loading strength.
Fascinatingly, the first two factors seem to represent the respective voluntary functions
of inhibition and generation. Inhibition, measured as error rate, is the ability to prevent a
response and instead correctly execute another action. Accordingly, the error rate variables
from all three voluntary eye movement tasks and measure of working memory strongly loaded
on the first, or Inhibition Factor. Generation, measured as response time, activates the
appropriate motor action. All voluntary response time variables except 0-back response time
loaded the second, or Generation Factor. The last two factors seem to represent different
oculomotor functions. 1-back and Working Memory Load error rates loaded the Working
Memory factor, whereas Prosaccade response time and error rate and Antisaccade response
time loaded the Basic Sensorimotor Performance factor.
Each eye movement factor was independently correlated with each diagnostic rating
scale, adjusting for age and the other three factors as covariates. Table 4.4 shows that the
Inhibition Factor correlated significantly with all three clinical measures (ADHD-IV: r(62) = 0.27,
p = 0.03; OCI-CV: r(62) = 0.32, p = 0.009; YGTSS: r(62) = 0.34, p = 0.006). The Generation
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Table 4.3 Factor analysis of eye movement variables
Factor Extracted

Variance Explained

Variables

Loadings

Inhibition

21.0%

0-back ER

0.844

Antisaccade ER

0.746

1-back ER

0.734

Working Memory Load ER

0.453

1-back RT

0.906

Working Memory Load RT

0.904

Antisaccade RT

0.504

Working Memory Load ER

0.671

1-back ER

0.513

Prosaccade RT

0.827

Antisaccade RT

0.622

Prosaccade ER

0.524

Generation

Working Memory

Basic Sensorimotor
Performance

20.3%

16.9%

16.9%

A variable was considered to have loaded a factor if its correlation (loading) with the factor was
greater than r = 0.450. ER, error rate; RT, response time
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Table 4.4 Correlations of eye movement factors with diagnostic rating scales
EM Factor

ADHD-IV

OCI-CV

YGTSS

r(62) = 0.27

r(62) = 0.32

r(62) = 0.34

p = 0.03

p = 0.009

p = 0.006

r(62) = 0.16

r(62) = 0.30

r(62) = 0.24

p = 0.20

p = 0.02

p = 0.05

r(62) = -0.14

r(62) = -0.10

r(62) = 0.02

p = 0.26

p = 0.44

p = 0.88

Basic Sensorimotor

r(62) = -0.03

r(62) = -0.03

r(62) = -0.08

Performance

p = 0.83

p = 0.80

p = 0.54

Inhibition

Generation

Working Memory

EM, eye movement; ADHD-IV, Attention Deficit Hyperactivity Disorder Rating Scale-IV; OCICV, Obsessive Compulsive Inventory – Child Version; YGTSS, Yale Global Tic Severity Scale;
Bold correlations are statistically significant.
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Factor correlated significantly with the OCD and tic scales (OCI-CV: r(62) = 0.30, p = 0.02;
YGTSS: r(62) = 0.24, p = 0.05). The Working Memory and Basic Sensorimotor Performance
factors did not strongly correlate with any of the three diagnostic rating scales.

Diagnostic Rating Scale Totals and Subscales
To determine if the aspects of TS captured by each clinical measure overlapped, I also
conducted a factor analysis of the diagnostic rating scale totals and subscales. See Appendix
A for a full list of each diagnostic rating scale’s subscales and the questions comprising them.
A variable was considered to have loaded a factor if its correlation (loading) with the factor was
greater than r = 0.45. Table 4.5 lists the four factors extracted, the amount of variance for
which they accounted, and the scale totals or subscales represented by each factor and at
what rotated loading strength.
The first factor, or Tic Severity factor, clearly represents the YGTSS, which assesses
phonic (vocal) and motor tic severity. Phonic tic subscales loaded more strongly than motor tic
subscales. The second factor, or ADHD/OCD factor, primarily represents the ADHD-IV total
and its two subscales, but also includes the OCI-CV total and four of its six subscales. The
OCI-CV total and a new mix of three of six subscales loaded onto factor three, or the OCD
factor. Finally, factor four, or Tic-related OCD factor, captures motor tics and the OCI-CV
Washing subscale. Figure 4.12 is a scatter plot of the ADHD/OCD and Tic Severity Factors.
These two factors correlated for Controls (r(28) = -0.69, p < 0.001), but not TS patients (r(38) =
-0.21, p = 0.21).
Lastly, the diagnostic rating scale factors (Tic Severity, ADHD/OCD, OCD, and Ticrelated OCD) were correlated with the eye movement factors (Inhibition, Generation, Harder
Task, and Easier Task), adjusting for age as a covariate. Table 4.6 reveals the ADHD/OCD
factor significantly correlated with the Inhibition factor (r(62) = 0.39, p = 0.001) and Generation
factor (r(62) = 0.27, p = 0.03).
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Table 4.5 Factor analysis of diagnostic rating scale totals and subscales
Factor Extracted

Variance Explained

Tic Severity

39.6%

ADHD/OCD

OCD

Tic-related OCD

19.7%

13.6%

9.1%

Subscales and Totals

Loadings

Phonic Tic Overall

0.929

Phonic Tic Number

0.907

Phonic Tic Intensity

0.878

Phonic Tic Complexity

0.872

Phonic Tic Frequency

0.868

Tic Global (Total) Score

0.858

Phonic Tic Interference

0.805

Motor Tic Number

0.759

Overall Life Impairment

0.747

Motor Tic Frequency

0.731

Motor Tic Overall

0.730

Motor Tic Interference

0.676

Motor Tic Intensity

0.673

ADHD Total

0.857

ADHD Inattention

0.815

ADHD Hyperactivity

0.806

OCD Obsessions

0.662

OCD Total

0.626

OCD Doubting/Checking

0.566

OCD Washing

0.484

OCD Neutralizing

0.452

OCD Hoarding

0.857

OCD Total

0.653

OCD Doubting/Checking

0.577

Motor Tic Interference

0.490

OCD Neutralizing

0.451

Motor Tic Complexity

0.788

OCD Washing

0.674

Motor Tic Overall

0.550

A variable was considered to have loaded a factor if its correlation (loading) with the factor was
greater than r = 0.450. See Appendix A for a list of each rating scale’s subscales and the
questions comprising them.
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Figure 4.12 TS and Control Tic Severity and ADHD/OCD Factors
Individual TS patient and Control ADHD/OCD Factor scores are plotted against Tic
Severity Factor scores.
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Table 4.6 Correlations of eye movement factors with diagnostic rating scale factors
EM Factor

Tic Severity

ADHD/OCD

OCD

Tic-related OCD

r(62) = 0.20

r(62) = 0.39

r(62) = -0.05

r(62) = 0.17

p = 0.11

p = 0.001

p = 0.69

p = 0.19

r(62) = 0.07

r(62) = 0.27

r(62) = 0.07

r(62) = 0.05

p = 0.60

p = 0.03

p = 0.61

p = 0.69

r(62) = 0.05

r(62) = -0.10

r(62) = -0.06

r(62) = -0.10

p = 0.72

p = 0.43

p = 0.65

p = 0.46

r(62) = -0.12

r(62) = -0.20

r(62) = 0.10

r(62) = 0.07

p = 0.36

p = 0.12

p = 0.44

p = 0.60

Inhibition

Generation

Harder Task

Easier Task

EM, eye movement; Bold correlations are statistically significant.
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Part 3 Summary
Separate factor analyses, one of the eye movement variables and another of the
diagnostic rating scale totals and subscales, each produced four interpretable factors. The first
two eye movement factors represented the voluntary functions of inhibition and generation,
respectively. The latter two factors seemed to signify oculomotor function, namely Working
Memory and Basic Sensorimotor Performance (Table 4.3). Only the Inhibition and Generation
factors significantly correlated with the total scores of the three clinical measures (Table 4.4).
Whereas the subscales loading most heavily on the first diagnostic rating scale factor
exclusively evaluated tic severity, those loading the second factor were a mix of ADHD and
OCD subscales. The third and fourth factors represented OCD and tic-related OCD,
respectively (Table 4.5). Tic severity and ADHD/OCD factor scores correlated for Controls, but
not TS patients (Figure 4.12). Of these diagnostic rating scale factors, only the ADHD/OCD
factor significantly correlated with the Inhibition and Generation factors (Table 4.6).
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5. Chapter 5

Discussion
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Despite the unwanted motor and vocal tics of TS, it is the highly prevalent comorbid
conditions of ADHD and OCD associated with increased tic severity that insidiously impair the
daily functioning of children with TS. This study clearly assessed the voluntary control abilities
of children with TS. As suggested by the Tonic Inhibition Model (Sereno, 1992), frontal cortex
regions regulate the basal ganglia’s tonic inhibitory output applied on midbrain structures.
Thus, it follows that impaired prefrontal cortex function will be evidenced by inferior voluntary
performance, perhaps in tandem with enhanced reflexive operation. The neuroanatomical
model outlined in Chapter 2 describes the role of basal ganglia-thalamocortical loops in
cognitive and motor control, anticipates behavioral deficits in individuals with TS, and predicts
how they are exaggerated by comorbid ADHD and/or OCD. Earlier oculomotor investigations
of cognitive control in TS ignored troublesome confounds, including medication, age, and
comorbidity. The current study shows cognitive control deficit is not attributable to TS alone,
but rather only when affiliated with increased symptom severities. In the final chapter, I will
discuss this surprising finding, anchor its conclusion to the literature, and present a revised
neuroanatomical model of TS and concomitant ADHD and OCD. In the process I will address
three questions: Are comorbid ADHD and OCD additional, or instead inherent, to TS? How
can children with only TS, who have obvious outward behavioral differences from typically
developing children (i.e., tics), not also display behavioral differences on voluntary saccadic
tasks of cognitive control? What, then, causes children with TS and ADHD and/or OCD to
show cognitive control deficits? I will close with comments on how this study’s conclusions can
translate into improved clinical care.

Collective Results
In TS patients, ADHD and OCD symptom severities correlated strongly with one
another. Additionally, tic severity increased positively with the symptom severities of both
ADHD and OCD. Thus, symptoms of all three disorders tended to increase in tandem. This
finding indicates comorbid ADHD and OCD are not self-contained components that often
appear in partnership with TS, but rather that ADHD and OCD symptomatology is present at
some level in the majority of TS patients, subthreshold to diagnosis in some and above
diagnostic threshold in others.
On the Prosaccade and Antisaccade tasks of Part 1, I expected both TS-only and TScomorbid patients to have a normally functioning reflexive system (normal Prosaccade
response time and error rate), but depleted voluntary control (impaired Antisaccade response
time and/or error rate) compared to Controls. This hypothesis was supported only partially.
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Whereas TS-comorbid patients did have normal reflexive performance and deficient voluntary
control, surprisingly neither TS-only patients’ reflexive nor voluntary control differed from that of
Controls. Just as symptom severities of all three disorders increase with one another and
Antisaccade response times and error rates increase in patients with elevated symptom
severities (i.e., TS-comorbid patients), perhaps these measures of voluntary function increase
on a sliding scale encompassing even TS-only patients. This possibility was corroborated by
the strikingly increased Antisaccade error rate evident in TS-only patients of higher tic severity
when separately compared to TS-only patients with lower tic severity and Controls. The latter
two groups did not differ in Antisaccade error rate. Thus, the data support the notion that as
frontal lobe function becomes progressively worse, symptoms become more severe.
On the 0-back and 1-back tasks of Part 2, I expected both TS-only and TS-comorbid
patients to have weak voluntary control (impaired 0-back and 1-back response time and/or
error rate). Furthermore, I expected the Working Memory Load (response time or error rate
performance difference between the 1-back and 0-back tasks) to be progressively greater on
TS-only and TS-comorbid patients compared to Controls. Working Memory Load, as a
difference measure, is a particularly accurate gauge of working memory, as it specifically
captures the impact of increased task demands on an individual and removes the influence of
other factors that may differ between the N-back tasks. As in Part 1, only a portion of the
hypothesis was substantiated. With elongated response times, elevated error rates, and
greater Working Memory Load, TS-comorbid patients demonstrated their voluntary control to
be lacking not only in comparison to Controls, but also to TS-only patients, as again TS-only
patients and Controls unexpectedly had comparable voluntary performance. The presence of
measureable deficits in TS-comorbid patients, who have more severely defective basal gangliathalamocortical loops than TS-only patients, supports the idea that as basal gangliathalamocortical loops become gradually more damaged, frontal lobe voluntary control suffers.
In the factor analyses of Part 3, eye movement variables loaded onto four orthogonal
(non-correlative) factors. Thus, Inhibition and Generation factors likely represent distinct
voluntary processes, which correlate with the total scores of all three diagnostic rating scales.
Hence, as symptom severities increase, inhibition and generation are progressively lacking. As
for the factor analysis of diagnostic rating scales, subscales of the YGTSS are highly related
and loaded the first factor. A mix of ADHD-IV and OCI-CV subscales next best accounted for
the variance in clinical data. Interestingly, while the Hoarding, Doubting/Checking, and
Neutralizing subscales of the OCI-CV loaded the third factor, only the Washing subscale
loaded the fourth. Perhaps this division is influenced by the fact that symmetry obsessions and
hoarding, touching, and counting compulsions are more common in patients with TS and OCD
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than contamination obsessions and washing/cleaning compulsions, which more often afflict
patients with OCD alone (de Groot and Bornstein, 1994; Leckman et al., 1994a; Cath et al.,
2001).
In sum, I interpret the data to indicate (1) ADHD and OCD symptoms are present at
some level in most all TS patients, because severities of these three disorders increase
together, (2) orienting in TS patients with increased symptom severities follows the cognitive
theory that inadequate volitional control produces normal or hyper-reflexive responses, (3)
involvement of aberrant basal ganglia-thalamocortical loops leads to progressively more
pronounced cognitive control impairments, specifically response inhibition, response
generation, and working memory, and (4) eye movement variables and clinical data can be
reduced separately into meaningful factors.

ADHD and OCD in TS: Additional or Integral?
As the controversial revisions of the DSM-IV are currently in committee, the debate
whether to define mental disorders categorically or dimensionally is as germane as ever.
Current standards use a categorical description, with discrete criteria to place a binary
diagnosis on an individual. A dimensional approach, however, acknowledges the effluence of
one disease into another and considers continuous severity of symptoms. One could argue the
different frontostriatal underpinnings of TS and comorbid ADHD and OCD warrant a categorical
approach. Growing evidence, however, calls for a dimensional method encompassing the
shared phenotypes and overlapping frontostriatal circuitry of these developmental disorders.
Some have doubted that what is currently categorically described as three concomitant, yet
independent disorders, may in fact be the random parcellation of a solitary entity (Klein and
Riso, 1993). For TS, comorbid ADHD and OCD may not be distinct, but rather intrinsic in TS.
The debate whether ADHD and OCD are additional, or instead integral, to TS started
decades ago. Most studies based their stance on behavioral and epidemiological data.
Comings and Comings, after extensive study, concluded ADHD is an integral aspect of TS
(Comings and Comings, 1984, 1985, 1987). Later, this same group argued for a genetic
relationship between ADHD and TS (Knell and Comings, 1993). While the Pauls group
acknowledged the concurrence of ADHD and TS (Pauls et al., 1986a), they posited two types
of TS with comorbid ADHD, one in which ADHD and TS independently coexist and another in
which ADHD is secondary to TS (Pauls et al., 1993). While the evidence for overlap and
genetic relationship between OCD and TS is strong (Frankel et al., 1986; Pauls et al., 1986b),
some studies still offered controversy (Black et al., 1992; Shapiro and Shapiro, 1992).
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Shared clinical manifestations of tics, compulsions, and behavioral disturbances seem
to suggest similar neural circuits underlie them. As symptoms worsen, are these circuits
involved in succession or in parallel? A scatter plot of the symptom severities of two disorders
can reveal clues of their neurobiological relationship. A plot with an initial slope of zero, which
at some point spikes upward, signals the additive involvement of neural circuits. Critically,
though, if TS and comorbid ADHD and OCD share a common neural substrate, their respective
symptoms should correlate (Spessot and Peterson, 2006). Indeed, in my patient sample, TS,
ADHD, and OCD symptom severity correlated with one another. Zhu and colleagues also
found that tic severity correlated with attention problems and thought problems, as measured
by the Child Behavior Checklist (Zhu, et al., 2006). While they did not use global tic severity as
I did, their correlation values for YGTSS motor and phonic subscales ranged between r = 0.32
and 0.52 (p < 0.05 to p < 0.01) for attention problems and r = 0.28 and 0.33 (p < 0.01) for
thought problems. This ADHD-tic symptom severity correlation was stronger than mine (r =
0.22) giving greater credence to the claim that ADHD is part and parcel with TS. My study’s
OCD-tic symptom severity correlation value (r = 0.35) is similar to that of Zhu and colleagues.
Of interest, Cath and colleagues qualitatively confirm this, stating the primary difference among
TS patients with and without OCD is increased symptom severity in TS patients with OCD
(Cath et al., 2000). Zhu and colleagues also report significantly increased attention and
thought problems in TS children with more severe tics compared to those with less severe tics.
This aligns with my findings not only of increased Antisaccade errors in the TS-only patients
with high tic severity, but also with impaired voluntary control in TS-comorbid patients (who also
tend to have more severe tics). These data point to parallel, gradually increasing symptom
severities matching with equivalently escalating behavioral performance deficits. This suggests
ADHD and OCD are integral to TS.
ADHD and OCD symptoms commonly coexist in TS, but is their pairing more or less
strong in the absence of TS? Mathews and colleagues demonstrated that inattention/
hyperactivity and obsessions/compulsions are present together in undergraduate students
(Mathews et al., 2004). The strength of their relationship (r = 0.28) was less than in the
typically developing children in my study (r = 0.42), but ADHD symptoms (Faraone et al., 2006)
as well as OCD symptoms (Bloch et al., 2009) are known to decline in adulthood. Regardless,
in both Mathews’ and my non-TS samples, ADHD and OCD symptoms were not as tightly
linked as in my TS patients. Therefore, ADHD and OCD uniquely interact in TS.
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TS-only Patients: Tics, but No Cognitive Control Impairments?
Owing to known frontostriatal dysfunction, patients with TS are expected to have
neuropsychological deficits in addition to their tics (Eddy et al., 2009). These impairments
could include visuomotor deficits, attention deficits, or executive deficits encompassing
inhibition and working memory break down. Indeed, cognitive impairments in other movement
disorders of basal ganglia origin, like Parkinson’s disease (Gabrieli et al., 1996; Weintraub et
al., 2005) and Huntington’s disease (Lawrence et al., 1998; Montoya et al., 2006), have been
linked to basal ganglia-thalamocortical circuit dysfunction. So, too, have many studies reported
cognitive deficit in individuals with TS. As in previous eye movement studies, however, most
study designs prevent complete attribution of deficit to TS, but rather to the culprits of
medication, age, and comorbid status.
Echoing the findings of my eye movement investigation in TS, the neuropsychological
literature largely finds cognitive control deficits only in TS children with comorbid disorders. My
review here will discuss only studies in children with TS, although the same issues stand in
adults (Eddy et al., 2009). On tests of working memory, Verte and colleagues reported children
with TS to have impairment, however 22 of 24 subjects had comorbid ADHD and/or OCD
(Verte et al., 2005). Poysky and colleagues attributed the working memory deficits in their
study to the influence of coexistent ADHD (Poysky et al., 2006). In fact, Martha Denckla,
doyenne of ADHD research, remarked that after a decade of research with TS children free of
ADHD, she could not find the substandard motor control or executive control typifying children
with ADHD alone or TS with ADHD (Denckla, 2006). Perhaps most applicable to my study,
children with pure TS showed no confirmation of working memory deficit on an N-back verbal
working memory task (Crawford et al., 2005).
With the unintended release of tics in TS, inhibitory control deficits are expected to be
central to TS. On a Go-No Go task, children with TS were impaired, although several patients
in this study had OCD (Muller et al., 2003). Couple this with another Go-No Go study in which
inadequate performance was found only in patients with OCD, not in children with
uncomplicated TS or controls (Watkins et al., 2005). In strong corroboration of my findings,
Ozonoff and colleagues found reduced inhibitory function on a negative priming task not only
exclusive to TS patients with comorbid ADHD and/or OCD, but also patients of high symptom
severity (tics, inattention/hyperactivity, and obsessions/compulsions), not patients with low
symptom severity (Ozonoff et al., 1998). They concluded that cognitive control impairment is a
function of both comorbidity and global symptom severity. In sum, children with TS have no
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general cognitive impairments, except when accompanied by comorbid conditions (Como,
2001).
Yet, if the presence of tics obviously distinguishes TS-only patients from typically
developing children, why do the implicated basal ganglia-thalamocortical circuits not also
produce reduced cognitive control? For a possible answer, we can turn to neuroimaging, which
provides direct evidence for the involvement of distinct brain areas. Most work in TS has
scrutinized subcortical basal ganglia volumes, but recent work has focused on the cortical
origins of the multiple basal ganglia-thalamocortical circuits. In a seminal paper, Sowell and
colleagues reported thinning of gray matter layers in the sensorimotor cortices of children with
TS, providing express evidence for involvement of the Motor Loop in TS (see Chapter 1;
Sowell et al., 2008). Not only was thinning more pronounced in teens than children, but also
was coupled with more severe tics, paralleling the progression of tic severity through
adolescence. Specifically, while thinning in dorsal sensorimotor cortices inversely correlated
with worst-ever tic severity, thinning was most pronounced in ventral areas and directly
correlated with the number of simple facial tics. The ventral sensorimotor cortex is known to
control the musculature of the face, mouth, and larynx, the very structures most commonly
involved in simple tics. Fahim and colleagues recently replicated these exciting findings, which
link anatomy to symptoms, and reported that significant cortical thinning in sensorimotor
cortices inversely correlated with tic severity (Fahim et al., 2009).
Many imaging studies in TS have found significant changes in the DLPFC, the cortical
origin of the Dorsolateral Prefrontal Loop that enables spatial memory, executive function, and
attention. An early anatomical magnetic resonance imaging (MRI) study reported larger
DLPFC volume in children with TS compared to controls (Peterson et al., 2001). Further,
bilateral DLPFC thinning correlated inversely with tic severity (Sowell et al., 2008). So, too, in
the orbitofrontal cortex (OFC), the frontal lobe origin of the Lateral Orbitofrontal Loop involved
in inhibitory control, cortical volume negatively correlated with tic severity (Peterson et al.,
2001). Two groups found more white matter under these frontal lobe regions, implying more
connectivity with deep brain structures (Fredericksen et al., 2002; Hong et al., 2002).
Because increased DLPFC and OFC brain matter is associated with less tic severity,
several authors have interpreted these results as evidence of an adaptive, compensatory
mechanism (Peterson et al., 2001; Baym et al., 2008; for review, see Spessot et al., 2004).
This view is further supported by a functional MRI (fMRI) study in which effortful tic suppression
activated vast areas of the prefrontal cortex (Peterson et al., 1998). Moreover, TS patients had
increased electroencephalogram (EEG) coherence among sensorimotor, prefrontal, and
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frontomesial regions not only during voluntary tic suppression, but also during a Go-No Go
inhibition task (Serrien et al., 2005). Critically, patients had equivalent performance on the task
as controls, suggesting the increased coherence was behaviorally compensatory.
As increased tic severity in early adolescence is coupled with the rigid expectations of
school and social settings, youth with TS continually tap these prefrontal regions to suppress
tics. Over time, activity-dependent enlargement of prefrontal cortices builds the capacity for
inhibitory functions (Spessot et al., 2004). This change is known as neural plasticity, which in
humans can occur in just days (Pascual-Leone et al., 1995) or minutes (Classen et al., 1998).
The prefrontal cortex has long been connected with this type of self-regulatory control,
arbitrating working memory and inhibition (Fuster, 1989). The same frontal regions also
moderate the cognitive control of voluntary eye movements (Oculomotor Loop; for review, see
Hutton, 2008). Thus, in TS, while abnormalities of sensorimotor cortices underpin the presence
of tics, the enlarged prefrontal regions of DLPFC and OFC not only adaptively protect against
worse symptoms, but also enable the absence of measureable neuropsychological and eye
movement deficits.

TS-comorbid Patients: What Pathology Causes Cognitive Control Deficits?
Children with TS and comorbid ADHD and/or OCD are known to have cognitive
impairment on tasks assessing a wide range of neuropsychological functions. In fact, these
deficits are equal or greater to those found in children with ADHD or OCD alone. In a
behavioral study, children with TS and ADHD demonstrated no difference from children with
pure ADHD (Sukhodolsky et al., 2003). Further, these two groups showed more behavioral,
functional, and family disturbances than either controls or children with only TS. In OCD,
patients with tic-related OCD were found to have higher incidences of substance abuse, mood
disorders, and anxiety than either those with TS or OCD alone (Coffey et al., 1998). This
asserts that TS with OCD results in more clinical morbidity than either isolated condition. So,
what pathology contributes to inferior cognitive control in these comorbid patients?
Interestingly, the DLPFC and OFC, the same areas posited to compensate for tics and
potential cognitive control deficits in pure TS, have been implicated in the functional demise of
children with comorbid ADHD and OCD. Children with TS and ADHD were found to have
smaller frontal lobes than uncomplicated TS patients (Fredericksen et al., 2002). In particular,
Kates and colleagues identified less gray and white matter in the prefrontal cortex of children
with TS and ADHD compared to those with only TS (Kates et al., 2002). In a diffusion tensor
imaging study of a juvenile TS sample, the strength of the DLPFC connection to the caudate of
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the basal ganglia was found to inversely correlate with obsessive-compulsive behavior (Makki
et al., 2009). Thus, these abnormal frontal regions likely may lead to functional impairments in
children with TS and coexistent ADHD and/or OCD.
The DLPFC is not only abnormally smaller in children with TS and concomitant ADHD,
but also in children with ADHD alone. Youth with ADHD have smaller frontal lobes with less
underlying connective white matter (Castellanos et al., 2002; Mostofsky et al., 2002). Filipek
and colleagues located the cortical shrinkage and white matter depletion in children with ADHD
to be in the anterior-superior frontal lobe (region including DLPFC; Filipek et al., 1997). The
DLPFC was specifically found to be smaller in children with ADHD alone (Sowell et al., 2003).
A longitudinal study reported kids with persistent ADHD have cortical thinning in DLPFC at
baseline and at follow-up an average of 5.7 years later compared to controls and patients with
remitted ADHD (Shaw et al., 2006). These data indicate abnormalities of the DLPFC contribute
to an aberrant Dorsolateral Prefrontal Loop particular to ADHD.
Although pediatric OCD patients have been included in very few neuroimaging studies,
the data implicate the OFC in OCD. Carmona and colleagues found decreased gray and white
matter in the inferior frontal lobes (region including OFC; Carmona et al., 2007; but see
Szeszko et al., 2008). In an fMRI study, both children with OCD and healthy controls
completed tests of inhibition – a stop task, a motor Stroop task of spatial interference, and a
switch task (Woolley et al., 2008). Children with OCD showed reduced activation of the OFC
and its subcortical targets compared to controls, demonstrating dysfunctional frontostriatal
circuitry. While patient performance did not differ statistically from controls, patients did show a
statistical trend toward worse performance on the Stroop and switch tasks. Limitations of the
study included a small patient sample size, 80% of whom were medicated, and all of whom
were in partial remission of OCD symptoms. These studies allude to an irregular OFC leading
to an impaired Lateral Orbitofrontal Loop in OCD.
The degree of comorbidity in a child has monumental ramifications on the extent of his
or her functional impairment. As both the number and severity of comorbidities increase, so,
too, do behavioral disturbances (Caron and Rutter, 1991). In fact, the level of comorbidity may
represent the extent of underlying pathophysiology in terms of brain function and lead to more
symptoms of greater severity (Freeman et al., 2000). For TS, perhaps initially enlarged DLPFC
and OFC enable dampened symptom severity and eased cognitive control deficit. But, as
volumes of DLPFC and OFC gray and white matter decrease, TS patients inevitably succumb
not only to more severe symptoms of TS, ADHD, and OCD, but also more severe functional
impairment. Restated, while enhanced DLPFC and OFC allow reduction of symptom severities
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and equivalent voluntary eye movement control in TS-only patients, emaciated DLPFC and
OFC expose greater overall symptom severity and poor voluntary eye movement control in TScomorbid patients.

Updated Model of Orienting in TS
The original model of orienting in TS (Figure 2.2) hypothesized weak frontal areas
would lead not only to impaired voluntary eye movement performance, but also to release of
the mid-brain reflexive control center from basal ganglia tonic inhibition, allowing normal or
hyperreflexive responding. The presence of comorbid ADHD and/or OCD, underpinned by
involvement of additional basal ganglia-thalamocortical circuits (see Figure 2.3), would
motivate further frontal weakness and poorer voluntary eye movement control. Results from
both Part 1 and 2, however, unexpectedly revealed TS-only patients to be free of eye
movement deficit, whereas only TS-comorbid patients demonstrated the predicted voluntary
eye movement dysfunction.
The updated model of orienting in TS (Figure 5.1) reconciles the seeming disconnect
between the presence of tics and the absence of voluntary eye movement impairment in
children with TS but without comorbid ADHD and OCD. Thinning of the sensorimotor cortex
and impairment of the Motor Loop leads to tics. Repeated activation of the DLPFC and LOFC
to suppress tics stimulates plastic hypertrophy of these stalwart prefrontal titans, achieving
augmented inhibitory reserves. Bolstered Dorsolateral Prefrontal and Lateral Orbitofrontal
Loops result in greater capacity for self-regulatory control, keeping otherwise rising symptom
severities in check. Benefits of this compensatory mechanism extend to the normalization of
potential deficits in eye movement measures of cognitive control.
An extension of this model encapsulates the neuroanatomical changes leading to the
worsened symptoms and voluntary eye movement deficits characterizing TS patients with
comorbid ADHD and/or OCD (Figure 5.2). Further thinning of the sensorimotor cortex leads to
a growing repertoire of tics, especially if simultaneous with shrinkage or stymied adaptive
growth of the DLPFC and/or LOFC. Progressively impaired Dorsolateral Prefrontal and Lateral
Orbitofrontal Loops lead to increased severities of ADHD and OCD symptoms, respectively.
Consequent reductions in self-regulatory control reveal eye movement deficits indicative of the
extent of pathophysiology.
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Figure 5.1 Updated model of orienting in Tourette Syndrome
Thinning of the motor cortex and impairment of the Motor Loop disinhibits the thalamus,
leading to tics. Repeated use of the DLPFC and LOFC to suppress tics leads to adaptive
growth of these prefrontal volumes and enhanced Dorsolateral Prefrontal and Lateral
Orbitofrontal Loops. The resulting boost to self-regulatory control keeps otherwise increasing
symptom severities in check and through the FEF and Oculomotor Loop permits normalization
of potential eye movement deficits. 1º Motor, primary motor cortex; FEF, frontal eye field;
DLPFC, dorsolateral prefrontal cortex; LOFC, lateral orbitofrontal cortex; SC, superior colliculus
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Figure 5.2 Updated model of orienting in Tourette Syndrome patients with comorbidities
Further thinning of the sensorimotor cortex and breakdown of the Motor Loop leads to a
growing repertoire of tics, especially if simultaneous with shrinkage or stymied adaptive growth
of the DLPFC and LOFC. Progressively impaired Dorsolateral Prefrontal and Lateral
Orbitofrontal Loops lead to increased severities of ADHD and OCD symptoms, respectively.
Consequent reductions in self-regulatory control involve the FEF and Oculomotor Loop,
revealing eye movement deficits indicative of the extent of pathophysiology. 1º Motor, primary
motor cortex; FEF, frontal eye field; DLPFC, dorsolateral prefrontal cortex; LOFC, lateral
orbitofrontal cortex; SC, superior colliculus
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This model is supported by the wealth of neuroimaging data reviewed above, but is not
without caveat. This model of orienting in TS holds only for children and adolescents, not
adults (who are the extreme minority of TS patients, see Chapter 1). While some
neuroimaging studies in adults with persistent TS report findings in line with that of children,
plenty others do not. For example, while less gray matter in the middle frontal gyrus of adults
with TS inversely correlates with tic severity and more white matter underlies this area (MüllerVahl et al., 2009), critically, adults with TS were found to have smaller DLPFC than agematched peers (Peterson et al., 2001). These data highlight the developmental nature of TS
and underscore the necessity to control for age.

Alternative Model
In Alexander and colleagues’ influential papers describing the neuroanatomy of the
basal ganglia-thalamocortical loops, they emphasized the parallel anatomical and physiological
nature of each loop (Alexander et al., 1986, 1990). In their description, the circuits all course
through the same structures, but never interconnect, establishing segregated, parallel loops.
Yet, this model focuses on the basal ganglia’s role in selecting and completing learned,
coordinated actions or emotions, not its more recently identified ability to learn behaviorally
relevant rules (Aosaki et al., 1994). The basal ganglia reinforce behavior, but also integrate
current situational cues to allow estimation of future events and execute proper responses. To
accommodate these functions, cross talk among functionally distinct loops is necessary (Haber,
2003).
The basal ganglia-thalamocortical loops consult with one another through several
mechanisms. First, while the general alignment of anatomical projections through each loop is
maintained, the broad dendritic arbors of neurons in adjacent loops often overlap along
adjoining functional areas. Further, the sharp reduction of structure size at each circuit level
subsequent to the cortex forces convergence of nerve terminals from neighboring functional
regions (Percheron and Filion, 1991; Yelnik et al., 1997; Yelnik, 2002). Whereas these means
of overlap are primarily at the functional edges of circuits, gross information sharing occurs
through several non-reciprocal connections. The motor (Motor), associative (Oculomotor and
Dorsolateral Prefrontal), and limbic (Lateral Orbitofrontal and Anterior Cingulate) loops not only
form traditionally-described “closed” circuits, which begin and end at the same cortical target,
but each loop also has one or more “open” pathways (Joel and Weiner, 1994). The cortical
target of an “open” pathway is not the loop’s originating cortical structure, but rather that of
another basal ganglia-thalamocortical loop. In this way, the motor, associative, and limbic
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circuits interact. Inter-loop communication also occurs subcortically, in striato-nigro-striatal
(Haber et al., 2000) and thalamo-cortico-thalamic pathways (McFarland and Haber, 2002). In
these feed forward routes, limbic regions of a subcortical loop structure (e.g., dorsal SNpr)
influence associative regions (e.g., medial SNpr), which interact with motor regions (e.g., ventral
SNpr).
Open, interconnected basal ganglia-thalamocortical loops are important to a
comprehensive view of TS. While a dysfunctional Motor Loop underlies symptoms of TS, an
aberrant Dorsolateral Prefrontal Loop triggers symptoms of ADHD, and a damaged Lateral
Orbitofrontal Loop prompts symptoms of OCD, these clinical signs do not appear or progress
independently in TS. In contrast, symptoms of the comorbid triad increase in parallel and may
be accommodated by overlapping information flow through basal ganglia-thalamocortical loops.
Hence, TS patients with mild overall symptoms and undetectable cognitive control impairments
may have moderately affected pathways, while those with more severe global symptoms and
measureable cognitive control deficits may have extensive disruption of interconnected loops.

Future Directions
I personally will use the three diagnostic rating scale scores from this study to develop a
single composite score (z-score) for each participant. With this z-score, patients will be divided
into those with lower or higher overall symptom severity. This is a more accurate division of
symptom severities from my current division into those with or without comorbidities, because it
also accounts for tic severity. Analysis of eye movement performance can be repeated to see
if a more significant difference exists between patient severity groups, corroborating my model
in which cognitive control deficits increase with overall symptom severity.
Another potential direction is to assess the efficacy of common TS pharmacotherapies
to improve cognitive control in TS. Children with TS can be tested on tasks of reflexive and
voluntary eye movement control before treatment as a baseline measure. After several weeks
of drug administration when effectiveness is optimal, patients can be retested to quantitatively
determine the improvement of the child’s cognitive control due to the medicine.
Finally, as a postdoctoral fellow with Pramod Dash, Ph.D., I will search for candidate
salivary protein biomarkers of TS. With high performance liquid chromatography (HPLC) and
tandem mass spectrometry, I will investigate Control and TS patients’ saliva samples for a
protein(s) that is in a significantly different quantity(ies). The identity of this candidate protein
biomarker(s) will be confirmed by enzyme-linked immunosorbent assay (ELISA).
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Implications for Changed Clinical Care
Much evidence supports the deleterious clinical and functional impact of increased tic
and comorbid symptom severities in TS. Comorbid conditions, though, are more functionally
impairing than tics themselves (Spessot and Peterson, 2006). ADHD is unmistakably the main
cause of behavioral, emotional, and cognitive deficit in TS (Spessot and Peterson, 2006).
Case in point, children with TS and ADHD have a risk of academic problems four times as
great as TS patients without ADHD (Erenberg et al., 1986; Abwender et al., 1996; Schuerholz
et al., 1996). Because ADHD leads to more strained social interaction, an early diagnosis of
ADHD in TS and subsequent psychosocial coaching may directly improve quality of life (Carter
et al., 2000). OCD, too, with increased anxiety, substance abuse, and mood disorders, may
bestow a greater functional burden than TS or OCD alone (Coffey et al., 1998). Thus,
proactive clinical intervention is direly needed to reduce the effect of comorbid conditions in TS.
Perhaps preventive behavioral therapy could be effective in minimizing future impact of
elevated symptom severities in TS. Therapists could employ neuropsychological tasks to
strengthen the planning, working memory, and cognitive flexibility of the DLPFC and the
reward-motivated, inhibitory processes of the LOFC. This approach has at least two potential
benefits. First, reinforced control in these prefrontal cortex regions may produce the activitydependent plasticity necessary to stave off the progression of symptoms and associated
functional impairment. Second, rather than wait until the patient is mired in troubles at school
and home, proactive training in recognizing significant triggers, problem events, and associated
feelings as well as navigating complex responsibilities (e.g., school demands) can better equip
the patient for inevitable struggles.
This study quantitatively established that ADHD and OCD symptoms are present in the
majority of TS patients, even if these symptoms are below diagnostic threshold. More exactly,
symptoms of comorbid conditions increase together with tic severity. Given tic severity
erratically waxes and wanes on both short and developmental time scales, even mild TS
patients may face hindering attentional and obsessional symptoms at some time. Thus,
clinicians must use vigilance to evaluate all TS patients for the full range of symptom severities.
Even families of TS patients presenting with little or no comorbid symptoms should be
educated on the possible course and impending impairment of increased symptoms. Pollak
and colleagues stress the need for this approach, “TS is itself a risk factor for behavioral
problems mandating that children with TS even if without ADHD and OCD still need to be
assessed and treated for psychopathology” (Pollak et al., 2009).
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To aid this endeavor, inclusion of a dimensional assessment could assist standard
categorical diagnostic procedures, not only enabling confirmation of the presence or absence
of a condition, but also the degree of expression (Hudziak et al., 2007). As neuropsychological
impairment is a function of both comorbid status and overall symptom severity, dimensional
assessment is the best predictor of current cognitive status (Ozonoff et al., 1998). In my study,
the combinatorial loading of subscales from several clinical measures onto a single factor (e.g.,
ADHD-IV and OCI-CV subscales) suggest that future work could create a new TS “superscale,”
or combination of the three current diagnostic rating scales to most fully evaluate overall
symptom severities. Overall, consideration of the complete amalgam of symptoms existing in
children with TS will ensure a greater understanding of their functional implications.
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6. Appendix A

Diagnostic Rating Scales
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List of Diagnostic Rating Scales and Subscales

Attention Deficit Hyperactivity Disorder Rating Scale – IV (ADHD-IV)
Inattention Subscale

(Odd numbered questions)

Hyperactivity Subscale

(Even numbered questions)

ADHD-IV Total

(Percentile Rank of Total Sum)

Obsessive Compulsive Inventory – Child Version (OCI-CV)
Obsessing Subscale

(Questions 1, 11, 14, and 18)

Washing Subscale

(Questions 2, 10, and 21)

Hoarding Subscale

(Questions 3, 7, and 16)

Doubting/Checking Subscale

(Questions 4, 5, 13, 15, and 20)

Neutralizing Subscale

(Questions 6, 9, and 12)

Ordering Subscale

(Questions 8, 17, and 19)

OCI-CV Total

(Sum of all Questions)

Yale Global Tic Severity Scale (YGTSS)
Motor Tic Number Subscale
Motor Tic Frequency Subscale
Motor Tic Intensity Subscale
Motor Tic Complexity Subscale
Motor Tic Interference Subscale
Motor Tic Overall Severity

(Sum of Motor Tic Subscales)

Phonic Tic Number Subscale
Phonic Tic Frequency Subscale
Phonic Tic Intensity Subscale
Phonic Tic Complexity Subscale
Phonic Tic Interference Subscale
Phonic Tic Overall Severity

(Sum of Phonic Tic Subscales)

Overall Life Impairment
Global Tic Severity Total

(Sum of Motor Tic Overall, Phonic Tic
Overall, and Overall Life Impairment
Subscales)
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ID #__________

Youth
Parent____________

Date___________________
Time___________________

Rating Scale
Please circle the number that best describes your child’s behavior over the past 6 months.
This is not a test, so there are no right and wrong answers.

1. Fails to give close attention to details or make careless
mistakes in schoolwork.
2. Fidgets with hands or feet or squirm in seat.

Never or Some- Often Very
Rarely times
Often
0
1
2
3
0

1

2

3

3. Has difficulty sustaining attention in tasks or play
activities.
4. Leaves seat in classroom or in other situations in which
remaining seated is expected.
5. Does not seem to listen when spoken to directly.

0

1

2

3

0

1

2

3

0

1

2

3

6. Runs about or climbs excessively in situations in which
it is inappropriate.
7. Does not follow through on instructions and fails to
finish work.
8. Has difficulty playing or engaging in leisure activities
quietly.
9. Having difficulty organizing tasks and activities.

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

10. Is “on the go” or acts if “driven by a motor”.

0

1

2

3

11. Avoids tasks (e.g., schoolwork, homework) that require
sustained mental effort.
12. Talks excessively.

0

1

2

3

0

1

2

3

13. Loses things necessary for tasks or activities.

0

1

2

3

14. Blurts out answers before questions have been
completed.
15. Is easily distracted.

0

1

2

3

0

1

2

3

16. Has difficulty awaiting turn.

0

1

2

3

17. Is forgetful in daily activities.

0

1

2

3

18. Interrupts or intrudes on others.

0

1

2

3
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ID #_________

Youth
Parent____________

Date______________
Time______________

Rating Scale
Please circle the number that best describes your child’s behavior over the past month.
This is not a test, so there are no right and wrong answers.
Example
Think a lot about dogs

Never
0

Sometimes
1

Always
2

1. Thinks about bad things and can’t stop.

Never
0

Sometimes
1

Always
2

2. Feels like they must wash and clean over and over
again.
3. Collects so much stuff that it gets in the way.

0

1

2

0

1

2

4. Checks many things over and over again.

0

1

2

5. After they have done things, they’re not sure if they
really did them.
6. Needs to count while they do things.

0

1

2

0

1

2

7. Collects things they don’t really need.

0

1

2

8. Gets upset if their stuff is not in the right order.

0

1

2

9. Gets behind in their schoolwork because they
repeat things over and over again.
10. Worries a lot about things being clean.

0

1

2

0

1

2

11. Gets upset by bad thoughts.

0

1

2

12. Have to say some numbers over and over.

0

1

2

13. Even after they’re done, they still worry they didn’t
finish things.
14. Gets upset by bad thoughts that pop into their head
when they don’t want them to.
15. Checks doors, windows, and drawers over and over
again.
16. Don’t throw things away because they’re afraid they
might need them later.
17. Gets upset if people change the way they arrange
things.
18. If a bad thought comes into their head, they need to
say certain things over and over.
19. Needs things to be in a certain way.

0

1

2

0

1

2

0

1

2

0

1

2

0

1

2

0

1

2

0

1

2

20. Even when they do something very carefully, they
don’t think they did it right.
21. Washes their hands more than other kids.

0

1

2

0

1

2
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ID #_________

Youth
Parent____________

Date______________
Time______________

Tic Severity Scale
Part I. Please mark the tics below that have been present during the past week.
A. Simple Motor Tics
(rapid, darting, ‘meaningless’ movements)
_____ Eye blinking
_____ Eye movements
_____ Nose movement
_____ Mouth movements
_____ Facial grimace (wince)
_____ Head jerks/movements
_____ Shoulder shrugs
_____ Arm movements
_____ Hand movements
_____ Abdominal (stomach) movements
_____ Leg, foot, or toe movements
_____ Other_________________________
_________________________
B. Complex Motor Tics
(slower, ‘purposeful’ movements)
_____ Eye gestures or movements
_____ Mouth movements
_____ Facial movements or expressions
_____ Head gestures or movements
_____ Shoulder gestures
_____ Arm or hand gestures
_____ Writing tics
_____ Distorted, abnormal postures
_____ Bending or gyrating
(twisting, writhing)
_____ Rotating
_____ Leg, foot, or toe movements
_____ Tic-related compulsive behaviors
(touching, tapping, grooming, evening-up)
_____ Involuntary obscene or forbidden
gestures
_____ Self-abusive behavior (describe)
_____________________________
_____ Outbursts of tics (displays),
duration _________seconds
_____ Other_________________________
_____________________________

_____ Describe any elaborate,
choreographed patterns or
sequences of motor tics
_____________________________
_____________________________
C. Simple Phonic Symptoms
(fast, ‘meaningless’ sounds)
_____ Coughing
_____ Throat clearing
_____ Sniffing
_____ Grunting
_____ Whistling
_____ Animal or bird noises
_____ Other_________________________
_________________________

D. Complex Phonic Symptoms
(language: words, phrases, statements)
_____ Syllables (list)__________________
_____ Words (list)____________________
_____ Stuttering (list)_________________
_____ Speech interruption by tongue, lips,
or vocal chord freezing___________
_____ Involuntary obscene or forbidden
words or remarks (list)___________
_____________________________
_____ Repeating another’s words
(describe) _____________________
_____ Repeating one’s own words
(describe) _____________________
_____ Disinhibited speech (immediate
impulsive response) (describe)
_____________________________
_____ Describe any elaborate,
choreographed patterns or
sequences of phonic tics
_____________________________
_____________________________
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ID #_________

Youth
Parent____________

Date______________
Time______________

Part II. Rate motor and phonic tics separately, unless otherwise indicated.
Using the following scale, rate the number of:
_____ motor tics (selected in sections A and B) present during the past week.
_____ phonic tics (selected in sections C and D) present during the past week.
0
1
2
3
4
5

None
Single kind of tic (eye blinking, for example)
Multiple kinds of tics (2-5) (eye blinking and nose movements, for example)
Multiple kinds of tics (>5)
Multiple kinds of tics plus at least one elaborate, choreographed pattern of multiple
simultaneous or sequential tics where it is difficult to distinguish distinct tics.
Multiple kinds of tics plus several (>2) elaborate, choreographed patterns of multiple
simultaneous or sequential tics where it is difficult to distinguish distinct tics.

Using the following scale, rate the frequency of:
_____ motor tics (selected in sections A and B) present during the past week.
_____ phonic tics (selected in sections C and D) present during the past week.
0
1

None.
Rarely.

2

Occasionally.

3

Frequently.

4

Almost Always.

5

Always.

No evidence of specific tic behaviors.
Specific tics have been present during the past week. These
behaviors occur infrequently, often not on a daily basis. If bouts
(attacks) of tics occur, they are brief and uncommon.
Specific tics are usually present on a daily basis, but there are
long tic-free intervals during the day. Bouts (attacks) of tics may
occur on occasion and are not sustained for more than a few
minutes at a time.
Specific tics are present on a daily basis. Tic-free intervals as
long as 3 hours are not uncommon. Bouts of tics occur regularly,
but may be limited to a single setting or environment.
Specific tics are present virtually every waking hour of every day,
and periods of sustained tics occur regularly. Bouts (attacks) of
tics are common and are not limited to a single setting or
environment.
Tics are present virtually all the time. Tic-free intervals are
difficult to identify and do not last more than 5 to 10 minutes at
most.

104

ID #_________

Youth
Parent____________

Date______________
Time______________

Using the following scale, rate the intensity of:
_____ motor tics (selected in sections A and B) present during the past week.
_____ phonic tics (selected in sections C and D) present during the past week.
0
1

Absent.
Minimal intensity.

2

Mild intensity.

3

Moderate intensity.

4

Marked intensity.

5

Severe intensity.

Tics are not visible or audible (exist only in patient’s private
experience) or tics are less forceful than comparable voluntary
actions and typically are not noticed because of their intensity.
Tics are not more forceful than comparable voluntary actions or
utterances and are typically not noticed because of their intensity.
Tics are more forceful than comparable voluntary actions, but are
not outside the range of normal expression for comparable
voluntary actions or utterances. They may call attention to the
individual because of their forceful character.
Tics are more forceful than comparable voluntary actions or
utterances. Such tics frequently call attention to the individual
because of their forceful and exaggerated character.
Tics are extremely forceful and exaggerated in expression.
These tics call attention to the individual and may result in risk of
physical injury (accidental, provoked, or self-inflicted) because of
their forceful expression.

Using the following scale, rate the complexity of:
_____ motor tics (selected in sections A and B) present during the past week.
_____ phonic tics (selected in sections C and D) present during the past week.
0
1
2

None.
Borderline.
Mild.

3

Moderate.

4

Marked.

5

Severe.

If present, all tics are clearly ‘simple’ (sudden, brief, purposeless).
Some tics are not clearly ‘simple’ in character.
Some tics are clearly ‘complex’ (purposive in appearance) and
mimic brief ‘automatic’ behaviors, such as grooming, syllables, or
brief meaningful utterances such as ‘uh huh,’ or ‘hi,’ that could be
readily camouflaged.
Some tics are more ‘complex’ (more purposive and sustained)
and may occur in elaborate bouts (attacks) that would be difficult
to camouflage, but could be rationalized or ‘explained’ as normal
behavior or speech (picking, tapping, saying ‘you bet’ or ‘honey,’
brief repeating of another’s words).
Some tics are very ‘complex’ in character and tend to occur in
sustained elaborate bouts that would be difficult to camouflage
and could not be easily rationalized as normal behavior or speech
because of their duration and/or their unusual, inappropriate,
bizarre, or obscene character (a lengthy facial contortion,
touching genitals, repeating another’s words, longer bouts of
saying ‘what do you mean’ repeatedly, or saying ‘fu--’ or ‘sh--’).
Some tics involve lengthy bouts of elaborate behavior or speech
that would be impossible to camouflage or successfully
rationalize as normal because of their duration and/or extremely
unusual, inappropriate, bizarre, or obscene character (lengthy
displays or utterances often involving self-abusive behavior or
involuntary obscene or forbidden gestures, words, or remarks).
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ID #_________

Youth
Parent____________

Date______________
Time______________

Using the following scale, rate the interference of:
_____ motor tics (selected in sections A and B) present during the past week.
_____ phonic tics (selected in sections C and D) present during the past week.
0
1

None.
Minimal.

2

Mild.

3

Moderate.

4

Marked.

5

Severe.

When tics are present, they do not interrupt the flow of behavior
or speech.
When tics are present, they occasionally interrupt the flow of
behavior or speech.
When tics are present, they frequently interrupt the flow of
behavior or speech.
When tics are present, they frequently interrupt the flow of
behavior or speech, and they occasionally disrupt future intended
action or communication.
When tics are present, they frequently disrupt future intended
action or communication.

Using the following scale, rate the impairment of:
_____ motor and phonic tics combined (selected in sections A-D) present during the past
week.
0
10

None.
Minimal.

20

Mild.

30

Moderate.

40

Marked.

50

Severe.

Tics are associated with subtle difficulties in self-esteem, family
life, social acceptance, or school or job functioning (infrequent
upset or concern about tics compared to the future; periodic,
slight increase in family tensions because of tics; friends or
acquaintances may occasionally notice or comment about tics in
an upsetting way).
Tics are associated with minor difficulties in self-esteem, family
life, social acceptance, or school or job functioning.
Tics are associated with some clear problems in self-esteem,
family life, social acceptance, or school or job functioning (feel
depressed, anxious, or irritable; periodic distress and upheaval in
the family, frequent teasing by peers or social avoidance).
Tics are associated with major difficulties in self-esteem, family
life, social acceptance, or school or job functioning.
Tics are associated with extreme difficulties in self-esteem, family
life, social acceptance, or school or job functioning (severe
depression with thoughts or plans about suicide, disruption of the
family [separation/ divorce, residential placement], disruption of
social ties – severely restricted life because of social stigma and
social avoidance, removal from school or loss of job).

106

Background Questionnaire
ID#:

TASK ORDER

DATE OF BIRTH:
3rd

EDUCATION:

____

SEX:

M

F

HANDEDNESS:

L

R

4th

5th

6th

7th

8th

Jr

Sr

Fr

So

ETHNICITY:
Ethnicity / Racial Category
American Indian / Alaska
Native
Asian
Hawaiian or Islander
Black or African American
White
More than one race
Unknown
VISION:

Hispanic or Latino Non-Hispanic or
Latino

Normal

Nearsighted

Farsighted

None

Glasses

Contacts

SURGERIES, OTHER NEUROLOGICAL DISORDERS OR DISEASES: NO
YES
(e.g., car accident, brain injury or tumor, cerebrovascular disease, epilepsy, stroke, eye
surgery, ADHD, OCD)
_____
FIRST DEGREE RELATIVES WITH NEUROLOGICAL DISORDERS:
NO
(e.g., Bipolar, Schizophrenia, Autism, Parkinson, Huntington, Tourette, ADHD, OCD)

YES
_____

========================================================================
DATE:

TIME:

CONDITION:

ON

OFF

CURRENT MEDICATIONS:

AM

PM

Control
NO

YES

Type:

_____

Dosage:

_____

Time since last Dose:

_____

107

DRUG ABUSE HISTORY:

NO

YES

ALCOHOL in last 24 hours:

NO

YES

SMOKING:

NO

YES
per day
Time since last cigarette:

CAFFEINE in last 24 hours:

NO

_____

YES

VIDEO GAMES:

hours per day/week

TV WATCHED:

hours per day/week

Have you ever had a streptococcal infection? If so, when?

_____

Have you ever taken nasal steroid spray medication?

_____

TS PATIENTS:

Age of Onset / Duration:
Motor tics

_____

Vocal tics

_____

During what situations are you most likely to have tics?

_____

Are you able to suppress your tics? If so, for how long?

_____

How do you know a tic is about to happen?

_____

YGTSS: Motor
ADHD: Inattention
OCD: Washing

IQ:

Phonic

Impairment

Global

Hyperactivity/Impulsivity
Checking

Ordering

Obsessing

Hoarding

Neutralizing

Full Scale

T-Score

Percentile

Total

____

Total

Clinical Measures:
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7. Appendix B

Sample Data Files
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Sample Data Output File – Task parameters and practice trials preceding a 0-back trial block
Testing TS7 at 10:03:55 AM on Saturday, August 30, 2008.
Number of trials = 96
Experiment is S.
EMs (well radius in pixels):
fixation = 110 pixels
target = 80 pixels
target distance : 266
Durations (ms):
fixation = 399 ms
target (pred exps) = 2998 ms timeout = 1492 ms
anticipation cutoff = 93 ms
anticipation trials discarded = 0 [0=keep, 1=discard]
Averages and speed criteria:
Fixn = 2
Speed = 2
Below = 2
Above = 8
Colors:
background = 0, fixation = 120, cue = 50, target = 255
Landmarks ON
Number of Targets = 4
Config Type = 1761605440 [0=On-Axis, 1=Off-Axis]
NBack ON
This was a 0 Back Run
Min locations in 1B sequence: 2
Max locations in 1B sequence: 3
Sequence Type [0=Random, 1=From file] : 1
Sequence File : FullSeq_4pos_96trials
Delay in 1B sequence: 350 msec
Target duration in 1B sequence: 80 msec
Fixation Off Delay: 500 msec
Last Target Off
Iscan sampling rate = 4
Screen refresh rate = 13328 microsec
Time between distance points 26 ms.
NOTE: for delayed & remembered, disinhibitions: -2 = correct, -3 = wrong
Eye Pos: 1=to the target, 2=to diagonally/vertically opposite side of tagret,
otherwise the location of the target closest to the eye position (target location labelled from 3 to
8, starting at [hor=right, vert=0] going anticlockwise)
Ts = response time relative to start of a trial (i.e. once stable fixation is achieved
Tb = response time relative to the begin of first target presentation
Te = response time relative to the end of last target presentation
Error position within a trial: 1 = Before target presentation, 2 = Before fixation erased in gap
paradigm
Error position within a trial: 3 = After fixation erased in gap paradigm, 4 = After target presented
but before target erased
Error position within a trial: 5 = After target erased but before fixation erased, 6 = After target
presented but before fixation erased
Error position within a trial: 7 = After go signal
Error position within a trial: 10+a = Error position within a trial: 10+a = During the N back
sequence when a=ordinal number of stimulus in sequence
Begin_______________________________________
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Trial
No

TargHF TargVF TargID Seq Eye
Cor
RT Duration
(L=-) (T=-)
Pos_H (err=0) (ms) (ms)
(R=+) (M=0)
(in=1) (cor=1)
(B=+)
1
0.00 -1.00 4
6-41
1
459.0 53.8
2
-1.00 0.00 5
3-6-5- 1
1
252.2 53.8
3
1.00 0.00 3
6-5-3- 1
1
239.8 24.8
4
0.00 -1.00 4
3-6-4- 1
1
272.9 37.2
5
1.00 0.00 3
4-35
0
454.8 20.7
6
0.00 1.00 6
4-61
1
339.1 41.3
7
-1.00 0.00 5
3-51
1
301.8 53.8
8
0.00 1.00 6
3-5-6- 1
1
264.6 70.3
There were 2 retrials because of eye movement.

NinSeq Ts Tb Te
(ms) (ms) (ms)
2
3
3
3
2
2
2
3

0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0

EP

0
0
0
0
0
0
0
0

Discarded Trials
Correct Column Codes: 2=MoveOut, 3=MoveOutGap, 4=Blink, 5=Timeout, 6=Antic
Trial TargHF TargVF TargID Seq Eye
Cor
RT Duration NinSeq Ts Tb Te EP
No
(L=-) (T=-)
Pos_H (err=0) (ms) (ms) (ms) (ms) (ms)
(R=+) (M=0)
(in=1) (cor=1)
(B=+)
1
0.00 1.00 6
0-0-0- 0
2
-4.1
0.0
3
26 -13 -13 1
2
-1.00 0.00 5
4-5-6- 6
2
-4.1
0.0
3
1212 799-13 13
Eye position data (Valid trials only)
Trial TargHFTargVFTargID Dist1 Dist2 Dist3 Dist4
Dist10
1
0.00 -1.00 4
-260 -262 -262 -265
2
-1.00 0.00 5
-250 -252 -246 -253
3
1.00 0.00 3
246
246
246
250
4
0.00 -1.00 4
-254 -248 -254 -254
5
1.00 0.00 3
252
253
250
250
6
0.00 1.00 6
301
300
300
300
7
-1.00 0.00 5
-284 -284 -287 -284
8
0.00 1.00 6
-299 -299 -293 -299
End_______________________________________

Dist5

Dist6

Dist7

Dist8

Dist9

-266
-248
249
-254
242
313
-281
-299

-278
-250
238
-248
243
308
-284
-287

-281
-262
246
-248
242
313
-280
-275

-274
-265
249
-248
246
319
-284
-275

-272
-251
252
-248
251
314
-294
-274
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Sample Eye Coordinates File – Part of a single trial
0
271
Sample X
1
491
2
491
3
500
4
500
5
503
6
498
7
498
8
498
9
502
10
506
11
502
12
502
13
498
14
497
15
497
16
504
17
498
18
498
19
501
20
497
21
497
22
500
23
503
24
504
25
505
26
504
27
504
28
504
29
501
30
489
31
494
32
498
33
503
34
498
35
484
36
491
37
498
38
498
39
491
40
495
41
496
42
500
43
496
44
492
45
499
46
499
47
499
48
495

Y
366
366
354
354
361
367
367
367
367
367
367
367
373
385
379
380
373
373
379
385
385
385
392
380
373
386
380
380
379
384
372
367
361
367
365
366
367
367
366
366
354
354
354
360
360
360
360
366

3997717
3997721
3997721
3997721
3997721
3997721
3997717
3997717
3997721
3997721
3997717
3997717
3997721
3997721
3997721
3997721
3997717
3997721
3997721
3997717
3997721
3997721
3997721
3997721
3997721
3997717
3997721
3997721
3997721
3997721
3997713
3997717
3997721
3997717
3997721
3997721
3997717
3997721
3997721
3997721
3997721
3997713
3997717
3997717
3997721
3997721
3997717
3997721
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Sample MATLAB Summary Output File – 0-back task variables for all control participants
Subject Trial Trim %Errors RTTrials Mean RT
(msec)

SEM RT
(msec)

*****************
Data for Task: 0 Back
*****************
CTS01
84
4.76
CTS02
91
3.30
CTS03
95
1.05
CTS04
91
1.10
CTS05
89
6.74
CTS06
94
9.57
CTS07
96
3.12
CTS08
82
3.66
CTS09
92
0.00
CTS10
88
5.68
CTS11
93
0.00
CTS12
90
3.33
CTS13
90
3.33
CTS14
90
1.11
CTS15
70
15.71
CTS16
85
3.53
CTS17
95
1.05
CTS18
92
1.09
CTS19
74
5.41
CTS20
94
1.06
CTS21
95
11.58
CTS22
95
1.05
CTS23
88
0.00
CTS24
88
1.14
CTS25
93
2.15
CTS26
94
3.19
CTS27
92
1.09
CTS28
93
1.08
CTS29
94
3.19
CTS30
88
4.55
CTS31
92
2.17
CTS32
92
0.00
CTS33
84
4.76
CTS34
92
2.17

12.75
8.89
9.57
7.17
12.35
13.99
6.61
16.85
10.97
15.47
9.69
8.51
11.06
12.00
9.22
7.00
5.76
9.42
12.97
13.53
11.90
15.72
11.12
8.42
9.62
7.81
7.18
9.59
9.78
11.26
8.50
8.32
13.34
6.04

80
86
90
90
80
84
91
79
89
81
92
84
85
89
58
79
92
88
69
92
82
92
86
85
88
89
88
90
88
81
87
88
79
86

328.64
309.46
312.98
294.30
440.02
409.18
322.02
382.19
365.65
463.62
341.36
355.61
360.84
351.00
234.36
260.57
282.62
324.73
271.27
329.61
348.00
416.77
337.31
295.24
393.69
353.90
276.95
299.78
386.93
448.13
348.69
320.56
321.08
311.70

Median RT
(msec)

296.70
307.40
303.30
288.00
443.00
386.20
319.60
355.60
363.60
440.90
328.60
359.40
343.00
338.64
195.50
253.40
281.10
307.60
195.50
307.80
321.90
396.50
312.10
282.90
386.80
339.00
275.90
303.70
367.80
436.20
334.00
308.85
305.75
306.30

SE of Median RT
(msec)

17.56
10.73
9.67
10.05
17.32
17.31
8.38
25.98
12.00
19.65
12.13
10.81
11.13
17.27
18.81
11.88
7.63
11.00
22.82
20.72
12.97
20.25
9.51
10.41
10.37
9.73
6.49
10.50
10.91
12.90
10.71
10.88
22.67
6.19
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